Emotions, Brain, Immunity, and Health: A Review

  • Theodore Melnechuk


In this review of research on emotions and immunity, in the context of psychobiology and psychosomatic medicine, emphasis is placed as much as possible on the physiological mechanisms whereby emotional responses and attitudes appear to affect disease resistance.


Autonomic Nervous System Positive Emotion Stressful Life Event Corticotropin Release Factor Natural Killer Cell Activity 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Achterberg, J., 1985, Imagery in Healing: Shamanism and Modern Medicine. New Science/Shambala, Boston.Google Scholar
  2. Ackerknecht, E.H., 1982, The history of psychosomatic medicine. Psychol Med, 12: 17–24.PubMedCrossRefGoogle Scholar
  3. Adams, E.M., Richardson Morton, K.D., Van de Kar, L.D., and Sanjal, M., 1987. The paraventricular nucleus modulates immune function. [Abstract] J Immunol, 16: 11.Google Scholar
  4. Adelman, G., (Ed.), 1987. “Encyclopedia of Neuroscience,” 2 vols. Birkhaeuser, Boston. Ader, R., 1981a, “A Historical Account of Conditioned Immunobiologic Responses,” In: Ader, (Ed.), op cit, pp 321–352.Google Scholar
  5. Ader, R., (Ed.), 1981b, “Psychoneuroimmunology,” Academic Press, New York. Ader, R., 1985, “Behaviorally Conditioned Modulation of Immunity,” In: Guillemin, et al, (Eds.), op cit, pp 55–69.Google Scholar
  6. Ader, R., and Cohen, N., 1985, CNS-immune system interactions: conditioning phenomena. Behav Brain Sci, 8: 379–426.CrossRefGoogle Scholar
  7. Ader, R., Grota, L.J., and Cohen, N., 1987, “Conditioning Phenomena and Immune Function,” In: Jankovic, et al, (Eds.), op cit, pp 532–544.Google Scholar
  8. Adey, W.R., 1987, “Electromagnetic Fields and the Brain Cell Microenvironment in Transmembrane Signaling,” In: Adelman, G., (Ed.), op cit, pp 376–378.Google Scholar
  9. Advances. Published quarterly by the Institute for the Advancement of Health, 16 East 53rd St., New York, NY 10022.Google Scholar
  10. Agius, M.A., Checinski, M.E., Richman, D.P., and Chelmicka-Schorr, 1987, Sympathectomy enhances the severity of experimental autoimmune myasthenia gravis (EAMG). [Abstract] J Immunol, 16: 11–12.Google Scholar
  11. Ahonen, J., Jibom, H., and Zederfelt, B., 1980, “Hormone Influences on Wound Healing,” In: “Wound Healing and Wound Infection,” Hunt, T.K., (Ed.), Appleton-Century-Crofts, New York, 99–104.Google Scholar
  12. Alexander, F., 1939, Psychological aspects of medicine. Psychosom Med, 1: 17–18.Google Scholar
  13. Alexander, F., 1950, “Psychosomatic Medicine,” Norton, New York.Google Scholar
  14. Amaducci, L., Bracco, L., Sorbi, S., Albanese, A., and Gainotti, G., 1983, Right and left differences of cholinergic system in the human temporal lobes. Int J Psychophysiol, 1: 108.Google Scholar
  15. American Cancer Society, 1982, Unproven methods of cancer management: O. C. Simonton. CA-A Cancer J for Clinicians, 32: 58–61.CrossRefGoogle Scholar
  16. Ames, B.N., 1983, Dietary carcinogens and anticarcinogens. Science, 221: 1256–1264.PubMedCrossRefGoogle Scholar
  17. Angeletti, R.H., and Hickey, W.F., 1985, A neuroendocrine marker in tissues of the immune system. Science, 230: 89–90.PubMedCrossRefGoogle Scholar
  18. Anisman, H., and Zacharko, R.M., 1983, Stress and neoplasia: Speculations and caveats. Behav Med Update, 5: 27–35.Google Scholar
  19. Anonymous, 1984, [Editorial.] Br Med J,1: 1163.Google Scholar
  20. Apffel, C.A., 1976, Nonimmunological host defenses: A review. Cancer Res, 36: 1527–1537. Armstrong, D., Sohal, R.S., Cutler, R.G., and Slater, T.F., (Eds.), 1984, “Free Radicals in Molecular Biology, Aging, and Disease,” Raven, New York.Google Scholar
  21. Arnetz, B.B., Wasserman, J., Petrini, B., Brenner, S.O., Levi, L., Eneroth, P., Salovaara, H., Hjelm, R., Salovaara, L., Theorell, T., and Petterson, I.L., 1987, Immune function in unemployed women. Psychosom Med, 49: 3–12.PubMedGoogle Scholar
  22. Aronowski, J., Dougherty, P.M., Samorajski, T., Pellis, N.R., and Dafny, N., 1985, Irradiation modifies the analgesic effects of morphine. Soc Neurosci Abstr, 11: 1200.Google Scholar
  23. Arrenbrecht, S., 1974, Specific binding of growth hormone to thymocytes. Nature (London), 252: 255–257.CrossRefGoogle Scholar
  24. Ax, A.F., 1953, The physiological differentiation between fear and anger in humans. Psychosom Med 15: 433–442.PubMedGoogle Scholar
  25. Axelrod, J., and Reisine, T.D., 1984, Stress hormones: Their interaction and regulation. Science, 224: 452–459.PubMedCrossRefGoogle Scholar
  26. Babloyantz, A., 1986, “Molecules, Dynamics, and Life: An Introduction to the Self-Organization of Matter,” Wiley, New York.Google Scholar
  27. Bachrach, L.L., 1975, Marital Status and Mental Disorder: An Analytical Review,“ U.S. Printing Office, Washington, DC.Google Scholar
  28. Bahnson, C.B., 1981, Stress and cancer: The state of the art. Part 1. Psychosomatics, 21: 975981. Part 2. Psychosomatics, 22: 207–220.PubMedGoogle Scholar
  29. Bahnson, C.B., and Bahnson, M.B., 1966, Role of the ego defenses: Denial and repression in the aetiology of malignant neoplasm. Ann N Y Acad Sci, 125: 827.PubMedCrossRefGoogle Scholar
  30. Baker, G.A., Santalo, R., and Blumenstein, J., 1977, Effect of psychotropic agents upon the histogenic response of human T-lymphocytes. Biol Psychiatry, 12: 159–169.PubMedGoogle Scholar
  31. Baker, G.B.H., 1987, Psychological factors and immunity. Invited review. J Psychosom Res, 31: 1–10.PubMedCrossRefGoogle Scholar
  32. Baker, G.B.H., and Brewerton, D.A., 1981, Rheumatoid arthritis: A psychiatric assessment. Br Med J, 282: 2014.CrossRefGoogle Scholar
  33. Baker, G.B.H., Irani, M.S., Byrom, N.A., Negvekar, N.M., Wood, R.J., Hobbs, J.R., and Brewerton, D.A., 1985, Stress, cortisol concentrations, and lymphocyte subpopulations. Br Med J, 290: 1393.CrossRefGoogle Scholar
  34. Bandura, A., 1985, Catecholamine secretion as a function of perceived coping self-sufficiency. J Counseling Clin Psychol, 58: 406–414.CrossRefGoogle Scholar
  35. Barnard, D., 1985, Psychosomatic medicine and the problem of meaning. Bull Menninger Clin, 29: 10–28.Google Scholar
  36. Barnes, D.M. 1986 ), Nervous and immune system disorders linked in a variety of diseases. Science, 232: 160–161.PubMedCrossRefGoogle Scholar
  37. Bar-Shavit, Z., Terry, S., Blumberg, S., and Goldman, R., 1982, Neurotensin-macrophage interaction: Specific binding and augmentation of phagocytosis. Neuropeptides, 2: 325335.Google Scholar
  38. Bartolome, J.V., Bartolome, M.B., Daltner, L.A., Evans, C.J., Barchas, J.D., Kuhn, C.M., and Schanberg, S.M., 1986, Effects of beta-endorphin on ornithine decarboxylase in tissues of developing rats: A potential role for this endogenous neuropeptide in the modulation of tissue growth. Life Sciences, 38: 2355–2362.PubMedCrossRefGoogle Scholar
  39. Bartrop, R.W., Luckhurst, E., Lazarus, L., Kiloh, L.G., and Penny, R., 1977, Depressed lymphocyte function after bereavement. Lancet, 1: 834–836.PubMedCrossRefGoogle Scholar
  40. Beecher, H.K., 1955, The powerful placebo. JAMA, 159: 1602–1606.CrossRefGoogle Scholar
  41. Beed, E.A., O’Dorisio, S., O’Dorisio, T.M., and Gaginella, T.S., 1983, Demonstration of a functional receptor for vasoactive intestinal polypeptide on Molt 4b T lymphoblasts. Regul Pept, 6: 1–12.PubMedCrossRefGoogle Scholar
  42. Beliauskas, L.A., 1983, Considerations of depression and stress in the etiology of cancer. Behav Med Update, 5: 23–26.Google Scholar
  43. Benson, D.F., 1984, The neurology of human emotion. Bull Clin Neurosci, 49: 23–42.PubMedGoogle Scholar
  44. Benson, D.F., and Zaidel, E., (Eds.), 1985, “The Dual Brain: Hemispheric Specialization in Humans,” Guilford, New York.Google Scholar
  45. Benson, H., 1975, “The Relaxation Response,” Morrow, New York.Google Scholar
  46. Benson, M., and Epstein, M.D., 1975, The placebo effect. A neglected asset in the care of patients. JAMA, 232: 1225–1227.PubMedCrossRefGoogle Scholar
  47. Berkman, L., Borysenko, J., Locke, S.E., Rogers, M., and Partridge, A., 1983, Psychosocial determinants of immunologically mediated diseases. Boston, Apr 15, 1983. [Conference report.] Advances 1(Intro): 27–29.Google Scholar
  48. Berkman, L., and Syme, S., 1979, Social networks, host resistance, and mortality: A nineyear follow-up study of Alameda County residents. Am J Epidemiol, 109: 186–204.PubMedGoogle Scholar
  49. Besedovsky, H., del Rey, A., and Sorkin, E., 1985, Immunological-neuroendocrine feedback circuits. In: Guillemin, et al, (Eds.), op cit, pp 163–177.Google Scholar
  50. Besedovsky, H., del Rey, A., Sorkin, E., and Dinarello, C.A., 1986, Immunoregulatory feedback between interleukin-1 and glucocorticoid hormones. Science, 233: 652–654.PubMedCrossRefGoogle Scholar
  51. Bistrian, B.R., Blackburn, G.L., and Scrimshaw, N.S., 1975, Cellular immunity in semistarved states in hospitalized adults. Am J Psychiatry, 28: 1148–1155.Google Scholar
  52. Bitar, K.N., and Makhlouf, G.M., 1982, Relaxation of isolated gastric smooth muscle cells by vasoactive intestinal peptide. Science, 216: 531–535.PubMedCrossRefGoogle Scholar
  53. Biziere, K., Guillaumin, J.M., Degenne, D., Bardos, P., Renoux, M., and Renoux, G., 1985, Lateralized neocortical modulation of the T-cell lineage. In: Guillemin, et al, (Eds.), op cit, pp 81–94.Google Scholar
  54. Blalock, J.E., 1984, The immune system as a sensory organ. J Immunol, 132: 1067–1070.PubMedGoogle Scholar
  55. Blalock, J.E., and Smith, E.M., 1985, A complete regulatory loop between the immune and neuroendocrine systems. Fed Proc 44: 108–111.PubMedGoogle Scholar
  56. Blennerhassett, M.G., Stead, R.H., and Bienenstock, J., 1987, Association and interaction between sympathetic neurons and mast cells in vitro. [Abstract] Biophys J, 51: 65a.Google Scholar
  57. Bloom, B.L., Asher, S.J., and White, S.W., 1978, Marital disruption as a stressor: A review and analysis. Psychol Bull 85: 867–894.PubMedCrossRefGoogle Scholar
  58. Bohn, M.C., Kessler, J.A., Adler, J.E., Markey, K.A., Goldstein, M., and Black, I.B., 1984, Simultaneous expression of the SP-peptidergic and noradrenergic phenotypes in rat sympathetic neurons. Brain Res 298: 378–381.PubMedCrossRefGoogle Scholar
  59. Boltwood, M., 1986, Cited in: Level of burn recovery linked to attitude of patient. Am Med News, May 9: 32.Google Scholar
  60. Borysenko, J., 1984, “Review of The Denial of Stress, edited by Schlomo Breznitz. Advances 1(4): 74–77.Google Scholar
  61. Boyd, W., 1966, “The Spontaneous Regression of Cancer,” Thomas, Springfield, Illinois. Braun, B., (Ed.), 1986, “Treatment of Multiple Personality Disorder,” American Psychiatric Press, Washington, D.C.Google Scholar
  62. Braun, B.G., 1983, Psychophysiological phenomena in multiple personality. An J Clin Hypn 26: 124–137.CrossRefGoogle Scholar
  63. Breznitz, S., (Ed.), 1983, “The Denial of Stress,” International Universities Press, Madison, Connecticut.Google Scholar
  64. Brittain, R.W., and Wiener, N.I., 1985, Neural and Pavlovian influences on immunity. Pavlovian J Biol Sci 20: 181–194.Google Scholar
  65. Bronson, G., 1987, Beyond the band-aid. Forbes June 1: 160–161.Google Scholar
  66. Brooks, C.M., 1987, Autonomic nervous system, nature and functional role. In: Adelman, (Ed.), op cit, pp 96–98.Google Scholar
  67. Brown, G.W., and Harris, T.O., 1978, “Social Origins of Depression,” Tavistock, London. Bulloch, K., 1985, Neuroanatomy of lymphoid tissue: A review. In: Guillemin et al, (Eds.), op cit, pp 111–141.Google Scholar
  68. Bulloch, K., and Bossone, S.A., 1987, Nerve-related 3S acetyl-cholinesterase in murine thymus. In: Jankovic et al, (Eds,.) op cit,pp 338–345.Google Scholar
  69. Burgus, R., Dunn, T.F., Desiderio, D., Ward, D.N., Vale, W., and Guillemin, R., 1970, Characterization of ovine hypothalamic hypophysiotropicGoogle Scholar
  70. TSH-releasing factor. Nature 226: 321–325.Google Scholar
  71. Burnet, F.H., 1965, Somatic mutations and chronic disease. Br Med J 1: 338–342.PubMedCrossRefGoogle Scholar
  72. Burnet, S.M., 1974, “Intrinsic Mutagenesis: A Genetic Approach to Ageing,” Wiley, New York.CrossRefGoogle Scholar
  73. Campbell, R., 1982, The lateralization of emotion: A critical review. Intern J Psychol 17: 211–229.CrossRefGoogle Scholar
  74. Cannon, W.B., 1914, The emergency function of the adrenal medulla in pain and the major emotions. Amer J Physiol 33: 356–372.Google Scholar
  75. Cannon, W., 1932, (2nd ed. 1963 ), “The Wisdom of the Body,” Norton, NY. Cannon, W.,1942, “Voodoo” death. Am Anthropol 44: 169.Google Scholar
  76. Cappel, R., Gregoire, F., Thiry, L., and Sprecher, S., 1978, Antibody and cell mediated immunity to herpes simplex virus in psychotic depression. J Clin Psychiatry 39: 266–268.PubMedGoogle Scholar
  77. Cassel, J., 1973, The relation of the urban environment to health: Implications for prevention. Mt Sinai J Med 40: 539–550.PubMedGoogle Scholar
  78. Cassileth, B.R., Lusk, E.J., Miller, D.S., Brown, L.L., and Miller, C., 1985, Psychosocial correlates of survival in advanced malignant disease? N Engl J Med 312: 1551–1555.PubMedCrossRefGoogle Scholar
  79. Cerutti, P., 1985, Prooxidant states and tumor promotion. Science 227: 375–381.PubMedCrossRefGoogle Scholar
  80. Cerutti, P., 1986, The role of active oxygen in tumor promotion. In: “Biochemical and Molecular Epidemiology of Human Cancer,” C. Harris (Ed.), Liss, New York, pp 167–176.Google Scholar
  81. Chelmicka-Schorr, E., Checinski, M.E., and Arnason, B.G.W., 1987, Sympathectomy augments the severity of experimental allergic encephalomyelitis (EAE) in rats. [Abstract.] J Immunol 16: 30–31.Google Scholar
  82. Clynes, M., 1973, “ Sentics: Biocybernetics of emotion communication” Annals NY Acad Sc 220, (3), 55–131.Google Scholar
  83. Clynes, M., 1977, “Sentics: The Touch of the Emotions”, Anchor Press/Doubleday, New York, pp 1–243.Google Scholar
  84. Clynes, M., 1983, Personal communication.Google Scholar
  85. Clynes, M., 1987, On music and healing In: “Music and Medicine,” R. Spintke & R. Droh (Eds.), Springer Verlag, Berlin, pp 13–31.Google Scholar
  86. Coe, C., Rosenberg, L.T., and Levine, S.,1987, Immunological consequences of psychological disturbance and maternal loss in infancy. In: “Advances in Infancy Research,” C. Rovee-Collier & L.P. Lipsitt (Eds.), Ablex, Norwood, New Jersey, in press.Google Scholar
  87. Cohen, J., Cullen, J.W., and Martin, L.R., 1982, “Psychosocial Dimensions of Cancer,” Raven, New York.Google Scholar
  88. Cohn, M., 1968, Molecular biology of expectation. In: “Nucleic Acids in Immunology,” I.J. Plescia & W. Brown (Eds.), Springer, New York, pp 671–715.CrossRefGoogle Scholar
  89. Cohn, M., 1985, What are the “must” elements of immune responsiveness? In: Guillemin, et al, (Eds.), op cit, pp 3–25.Google Scholar
  90. Collins, A., Downes, C.S., and Johnson, R.T., 1984, “DNA Repair and Its Inhibition,” IRL Press, Oxford, England.Google Scholar
  91. Collins, A., Johnson, R.T., and Boyle, J.M., 1987, Molecular biology of DNA repair. J Cell Sci suppl 6: 1–353.Google Scholar
  92. Connolly, J., 1985, Life happenings and organic disease. Br J Hospital Med 33: 24–27.Google Scholar
  93. Cooper, E.L., (Ed.), 1984, “Stress, Immunity, and Aging,” Dekker, NewYork.Google Scholar
  94. Cooper, J.R., Bloom, F.E., and Roth, R.H., 1986, “Neuroactive Peptides. The Biochemical Basis of Neuropharmacology,” ( 5th ed. ), Oxford University Press, New York, pp 352–393.Google Scholar
  95. Corballis, M.C., 1983, “Human Laterality,” Academic, New York.Google Scholar
  96. Cousins, N., 1976, The anatomy of an illness (as seen by thepatient). N E J Med 295: 1458 1463.Google Scholar
  97. Cousins, N.,1979, “The Anatomy of an Illness,”Norton, New York.Google Scholar
  98. Cousins, N., 1983, “The Healing Heart,” Norton, New York.Google Scholar
  99. Cousins, N., 1983, Personal communication.Google Scholar
  100. Cousins, N., 1985, Can creativity heal? [Review of Sandblom, P., 1985, Creativity and Disease.] Advances 2(3): 69–72.Google Scholar
  101. Cox, T., and Mackay C., 1982, Psychosocial factors and psychophysiological mechanisms in the aetiology and development of cancers. Soc Sci Med 16: 381–396.PubMedCrossRefGoogle Scholar
  102. Cunningham, A.J., 1984, Psychotherapy for cancer: A review. Advances 1(4): 8–14.Google Scholar
  103. Cunningham, A,J., 1985, The influence of mind on cancer. Canadian Psychology 26: 13–29.CrossRefGoogle Scholar
  104. Curti, R., Radice, L., Cesana, G.C., Zanettini, R., and Grieco, A., 1982, Work, stress and immune system: Lymphocyte reactions during rotating shift work. Preliminary results. Med Lavoro 290: 1393.Google Scholar
  105. Dafny, N., Dougherty, P., and Pellis, N.R., 1985, The effect of immunosuppression and opiates upon the visual evoked responses of cortical and subcortical structures. Soc Neurosci Abstr 11: 907.Google Scholar
  106. Danek, A., O’Dorisio, M.S., O’Dorisio, T.M., and George, J.M., 1983, Specific binding sites for vasoactive intestinal polypeptide on nonadherent peripheral blood lymphocytes. J Immunol 131: 1173–1177.PubMedGoogle Scholar
  107. Darko, D.F., Lucas, A.H., and Gillin, J.C., 1986, Replication of lower lymphocyte blastogenesis in depression [letter]. Am J Psychiat 43: 1492–1493.Google Scholar
  108. Davidson, R.J., 1983, Affect, repression, and cerebral asymmetry. In: Temoshok, et al, (Eds.), op cit, pp 123–135.Google Scholar
  109. Davies, T., 1987 ), Peculiar progress. [Review of Paradoxes in Immunology, Geoffrey W. Hoffman, Julia G. Levy, & Gerald T. Nepom (Eds.).] Nature 327: 110–111.Google Scholar
  110. Del Rey, A., Besedovsky, H., Sorkin, E., and Dinarello, C.A., 1987, Interleukin-1 and glucocorticoid hormones integrate an immunoregulatory feedback circuit. In: Jankovic, et al, (Eds.), op cit, 85–90.Google Scholar
  111. Devoino, L.V., and Alperina, E.L., 1985, Stimulation of the immune response by activation of dopaminergic system: Interaction with serotonergic system in neuroimmunomodulation. In: Spector, (Ed.), op cit, pp 124–128.Google Scholar
  112. Diamond, J.M., 1987, Infectious, genetic, or both? Nature 328: 199–200.PubMedCrossRefGoogle Scholar
  113. Dillon, K.M., Minchoff, B., and Baker, K.H., 1985–86, Positive emotional states and enhancement of the immune system. Int J Psychiatry Med 15: 13–17.Google Scholar
  114. Ditto, B., 1987, Sibling similarities in cardiovascular reactivity to stress. Psychophysiology, 24: 353–360.PubMedCrossRefGoogle Scholar
  115. Doherty, W.J., Baird, M.A., and Becker, L.A., 1986, Family medicine and the biopsychosocial model: The road toward integration. Advances 3(3): 17–28.Google Scholar
  116. Dohrenwend, B.S., and Dohrenwend, B.P., (Eds.), 1974, “Stressful Life Events: Their Nature and Effects,” Wiley, New York.Google Scholar
  117. Dorian, B., Garfinkel, P., Brown, G., Shore, A., Gladman, D., Keystone, E., 1982, Aberrations in lymphocyte subpopulations and function during psychological stress. Clin Exper Immunol 50: 132–138.Google Scholar
  118. Dorian, B., Garfinkel, P., Keystone, E., Gorczynski, R., Darby, P., and Garner, D., 1985, Occupational stress and immunity [abstract]. Psychosom Med 47: 77.Google Scholar
  119. Dowling, S.J., 1984, Lourdes cures and their medical assessment. J Roy Soc Med 77: 634–638. Dreher, H., 1986, The perspectives and programs of behavioral medicine. Advances 3(1): 8–21.Google Scholar
  120. Eccles, R., and Lee, R.L., 1981, The influence of the hypothalamus on the sympathetic innervation of the nasal vasculature of the cat. Acta Otolaryngol 91: 127–134.CrossRefGoogle Scholar
  121. Edwards, B., 1979, “Drawing with the Right Side of the Brain.,”Tarcher, Los Angeles. Ekman, P., Freisen, W.V., and Ellsworth, P., 1972, “Emotion in the Human Face,” Pergamon, New York.Google Scholar
  122. Ekman, P., Levenson, R.W., and Friesen, W.V., 1983, Autonomic nervous system activity distinguishes among emotions. Science 221: 1208–1210.PubMedCrossRefGoogle Scholar
  123. Ellendorf, F., and Parvizi, N., 1980, The endocrine function of the brain. In: “Role of Extrahypothalamic Centers in Neuroendocrine Integration,” M. Motta (Ed.), Raven, New York, pp 297–325.Google Scholar
  124. Engel, B.T., 1986, An essay on the circulation as behavior. Behav Brain Sci 9: 285–318. Engel, G.L., 1954, Selection of clinical material in psychosomatic medicine. Psychosom Med 16: 368–373.Google Scholar
  125. Engel, G.L., 1967, The concept of psychosomatic disorders. J Psychosom Res 11: 31–39. Engel, G.L., 1971, Sudden and rapid death during psychological stress. Ann Intern Med 74: 771–782.Google Scholar
  126. Engel, G.L., 1977, The need for a new medical model: A challenge for biomedicine. Science 196: 129–136.PubMedCrossRefGoogle Scholar
  127. Eremina, O.F., and Devoino, L.V., 1973, Production of humoral antibodies in rabbits following destruction of the nucleus of the midbrain raphe. Byull Eksp Biol Med 74: 258261.Google Scholar
  128. Ernster, B.L., Sacks, S., Selvin, S., and Petrakis, N.L., 1979 ), Cancer incidence by marital status: U.S. third national cancer survey. J Natl Cancer Inst 63: 578–585.Google Scholar
  129. Eskola, J., Ruuskanen, O., Soppi, E., Viljanen, M.K., Jarvinen, M., Toivonen, H., and Kouvalainen, K., 1981, Effect of sport stress on lymphocyte transformation and antibody formation. Clin Exp Immunol 32: 339–345.Google Scholar
  130. Evans, F.J., 1984, Unravelling placebo effects: Expectations and the placebo response. Advances 1(3): 11–20.Google Scholar
  131. Everson, T.C., and Cole, W.H., 1966, “Spontaneous Regression of Cancer,” Saunders, Philadelphia.Google Scholar
  132. Felten, D.L., Felten, S.Y., Carlson, S.L., Olschowka, J.A., and Livnat, S., 1985, Noradrenergic and peptidergic innervation of lymphoid tissue. In: Goetzl, (Ed.), op cit, pp 755s - 765s.Google Scholar
  133. Felten, S.Y., Olschowka, J.A., and Felten, D.L., 1987, Tyrosine hydroxylase positive nerve terminals contact lymphocytes in the periarteriolar lymphatic sheath of the rat splenic white pulp. Soc Neurosci Abstr 13: 1379.Google Scholar
  134. Ferguson, R.M., Schmidtke, J.R., and Simmons, R.L., 1976, Differential effects of chlorpromazine on the in vitro generation and effector function of cytotoxic lymphocytes. J Exp Med 143: 232–237.PubMedCrossRefGoogle Scholar
  135. Fischman, H.K., 1985, Personal communication.Google Scholar
  136. Fischman, H.K., and Kelly, D.D., 1987, Sister chromatid exchanges induced by behavioral stress. In: Jankovic, et al, (Eds.), op cit, pp 426–435.Google Scholar
  137. Flohe, L., Giertz, H., and Beckmann, R., 1985, Free radical scavengers as anti-inflammatory drugs? In: “Handbook of Inflammation, Vol 5: The Pharmacology of Inflammation,” I.L. Bonta, M.A. Bray, & M.J. Parnham (Eds.), Elsevier, New York, pp 255–270.Google Scholar
  138. Flor-Henry, P., 1983, “Cerebral Basis of Psychopathology,” Wright/PSG, Boston. Fox, B.H., 1978, Premorbid psychological factors as related to cancer incidence. J Behav Med 1: 45–113.Google Scholar
  139. Fox, B.H., 1981, Psychosocial factors and the immune system in human cancer. In: Ader, (Ed.), op cit, pp 103–157.Google Scholar
  140. Fox, B.H., and Newberry, B.H., 1984, “Impact of Psychoendocrine Systems in Cancer and Immunity,” Hogrefe, Toronto, Canada.Google Scholar
  141. Frankenhaeuser, M., 1975, Experimental approaches to the study of catecholamines and emotion. In: “Emotions, Their Parameters and Measurement,” L. Levi (Ed.), Raven, New York.Google Scholar
  142. Frankenhaeuser, M., 198,) Challenge-control interaction as reflected in sympathetic-adrenal and pituitary-adrenal activity: Comparison between the sexes. Scand J Psychol suppl 1: 158–164.Google Scholar
  143. Gainer, H., 1987, Neuropeptide precursors. In: Adelman, ( Ed.), op cit, pp 834–835.Google Scholar
  144. Gainotti, G., 1972, Emotional behavior and hemispheric side of lesion. Cortex 8: 41–45.PubMedGoogle Scholar
  145. Ganguli, R., Rabin, B.S., Kelly, R.H., Lyte, M., and Ragu, U., 1987, Clinical and laboratory evidence of autoimmunity in acute schizophrenia. In: Jankovic, et al, (Eds.), op cit, pp 676–685.Google Scholar
  146. Garfield, E., 1986, Psychoneuroimmunology: A new facet of the mind-body dialogue. Current Contents 1986 (May5): 3–11.Google Scholar
  147. Gellhorn, E., 1967, “Principles of Autonomic Somatic Integrations,” University of Minnesota Press, Minneapolis, Minnesota.Google Scholar
  148. Gensler, B., and Bernstein, H., 1981, DNA damage as a primary cause ofaging. Q Rev Biol 56: 279–303.PubMedCrossRefGoogle Scholar
  149. Gerendai, I., 1984, Lateralization of neuroendocrine control. In: “Cerebral Dominance: The Biological Foundations,” N. Geschwind & A.M. Galaburda (Eds.), Harvard University Press, Cambridge, Massachusetts, pp 167–178.Google Scholar
  150. Geschwind, N., and Galaburda, A.M., 1985, Cerebral lateralization. Brainmechanisms, associations, and pathology: A hypothesis and aprogram for research. Pt I Arch Neurol 42: 428–459. Pt II Arch Neural 42: 521–552. Pt III Arch Neural 42: 634–654.CrossRefGoogle Scholar
  151. Geschwind, N., and Galaburda, A.M., 1987, “Cerebral Lateralization: Biological Mechanisms, Associations, and Pathology,” MIT Press, Cambridge, Massachusetts.Google Scholar
  152. Chanta, V.K., Hiramoto, R.N., Solvason, H.B., and Spector, N.H., 1985, Neural and environmental influences on neoplasia and conditioning of NK activity. In: Goetzl, (Ed.), op cit, pp 848s - 852s.Google Scholar
  153. Gilad, G.M., 1987, The stress-induced response of the septo-hippocampal cholinergic system. A vectorial outcome of psycho-neuroendocrinological interactions. Psychoneuroendocrinology, 12: 167–184.PubMedCrossRefGoogle Scholar
  154. Gilman, S.C., Schwartz, J.M., Milner, R.J., Bloom, F.E., and Feldman, J.D., 1982, Beta-endorphin enhances lymphocyte proliferative responses. Proc Natl Acad Sci USA, 79: 4226–4230.PubMedCrossRefGoogle Scholar
  155. Glaser, R., Kiecolt-Glaser, J.K., Speicher, C.E., and Holliday, J.E., 1985, Stress, loneliness, and changes in herpesvirus latency. J Behav Med, 8: 249–260.PubMedCrossRefGoogle Scholar
  156. Glaser, R., Kiecolt-Glaser, K.C., Stout, J.C., Tarr, K.L., Speicher, C.E., and Holliday, J.E., 1985, Stress-related impairments in cellularimmunity. Psychiatry Res, 16: 233–29.PubMedCrossRefGoogle Scholar
  157. Glaser, R., Rice, J., Sheridan, J., Fertel, R., Stout, J., Speicher, C., Pinsky, D., Lotur, M., Post, A., Beck, M., and Kiecolt-Glaser, J., 1987, Stress-related immune suppression: Health implications. Brain Behavior Immunity,in press.Google Scholar
  158. Glaser, R., Rice, J., Speicher, C.E., Stout, J.C., and Kiecolt-Glaser, J.K., 1987, Stress depresses interferon production by leukocytes concomitant with a decrease in natural killer cell activity. Behavioral Neurosci,in press.Google Scholar
  159. Glaser, R., Thorn, B.E., Tarr, K.L., Kiecolt-Glaser, J.K., and D’Ambrosio, S.M., 1985, Effects of stress on methyltransferase synthesis: An important DNA repair enzyme. Health Psycho!, 4: 403–412.CrossRefGoogle Scholar
  160. Glenn, N.D., and Weaver, C.N., 1981, The contribution of marital happiness to global happiness. J Marriage Fam, 43: 161–168.CrossRefGoogle Scholar
  161. Glick, S.D., Meibach, R.C., Cox, R.D., and Maayani, S., 1979, Multiple and interrelated functional asymmetries in rat brain. Life Sci, 25: 395–400.PubMedCrossRefGoogle Scholar
  162. Goetzl, E.J., (Ed.), 1985, Neuromodulation of immunity and hypersensitivity. Jlmmunol, 135(suppl).Google Scholar
  163. Goldstein, A., 1976, Opioid peptides (endorphins) in pituitary and brain. Science, 193: 1081 1086.Google Scholar
  164. Goldstein, A., 1980, Thrills in response to music and other stimuli. Physiol Psycho!, 8: 126129.Google Scholar
  165. Goldstein, A.L., Rossio, J., Kolyaskina, G.I., Emory, L.E., Overall, j.E., Thurman, G.B., and Hatcher, J., 1980, Immunological components in schizophrenia. In: ‘Perspectives in Schizophrenia Research,“ C. Baxter & T. Melnechuk (Eds.), Raven, New York, pp 249–267.Google Scholar
  166. Goleman, D., 1935, Opioids and denial: Two mechanisms for bypassing pain. Advances, 2(3): 35–45.Google Scholar
  167. Gorczynski, R.M., Kennedy, M., and Ciampi, A., 1985, Cimetidine reverses tumor growth enhancement of plasmacytoma tumors in mice demonstrating conditioned immunosuppression. J Immunol, 134: 4261–4266.PubMedGoogle Scholar
  168. Gordon, B.L., 1935, “Medicine Throughout Antiquity,” Macmillan, New York.Google Scholar
  169. Gordon, J.S., 1980, The paradigm of holistic medicine. In: “Health for the Whole Person: The Complete Guide to Holistic Medicine,” A.C. Hastings, J. Fadiman, & J.S. Gordon (Eds.), Westview, Boulder, Colorado, pp 3–27.Google Scholar
  170. Gorman, J.R., and Locke, S.E., 1987, Neural, endocrine, and immune interactions. In: “Comprehensive Textbook of Psychiatry,” H. Kaplan & B. Sadock (Eds.), Williams & Wilkins, Baltimore. In press.Google Scholar
  171. Gott, P.S., Hughes, E.C., and Whipple, K., 1984, Voluntary control of two lateralized conscious states: Validation by electrical and behavioral studies. Neuropsychologia, 22: 65–72.PubMedCrossRefGoogle Scholar
  172. Gottschalk, L.A., Welch, W.D., and Weiss, J., 1982, Vulnerability and the immune response. Psychother Psychosom, 39: 23–35.CrossRefGoogle Scholar
  173. Green, L.W., Tryon, W.W., Marks, B., and Huryn, J., 1986, Periodontal disease as a function of life events stress. J Human Stress, 12: 32–36.PubMedCrossRefGoogle Scholar
  174. Greer, S., and McEwan, P.J.M., (Eds.), 1985 ), Cancer and the mind. Soc Sci Med, 20: 771–853. Greer, S., and Morris,T., 1975, Psychological attributes of women who develop breast cancer: A controlled study. J Psychosom Res, 19: 147-.Google Scholar
  175. Greer, S., and Watson, M., 1985, Towards a psychobiological model of cancer: Psychological considerations. Soc Sci Med, 20: 773–777.PubMedCrossRefGoogle Scholar
  176. Grinker, R.R., 1973, “Psychosomatic Concepts,” Revised ed. Jason Aronson, New York. Grossarth-Maticek, R., 1980, Social psychotherapy and course of the disease. First experiences with cancer patients. Psychother Psychosom, 33: 129–138.Google Scholar
  177. Grossarth-Maticek, R., Bastiaans, J., and Kanazir, D.T., 1985, Psychosocial factors as strong predictors of mortality from cancer, ischaemic heart disease and stroke: The Yugoslav prospective study. J Psychosom Res, 29: 167–176.PubMedCrossRefGoogle Scholar
  178. Grossarth-Maticek, R., Siegrist, J., and Vetter, H., 1982, Interpersonal repression as a predictor of cancer. Soc Sci Med, 16: 493–498.PubMedCrossRefGoogle Scholar
  179. Grossman, R., 1985, Ecumenical medicine. Advances, 2(4): 39–50.Google Scholar
  180. Guidotti, A., and Grandison, L., 1979, Participation of endorphins in the regulation of pituitary function. In: “Endorphins in Mental Health Research,” E. Usdin, W.E. Bunney Jr., & N.S. Kline (Eds.), Macmillan, New York, pp 416–422.Google Scholar
  181. Guillemin, R.G., Cohen, M., and Melnechuk, T., (Eds.), 1985, “Neural Modulation of Immunity,” Raven, New York.Google Scholar
  182. Guth, L., 1987, Trophic effects. In: Adelman, G., (Ed.), op cit, pp 1237–1238.Google Scholar
  183. Hadden, J.W., 1987, Neuroendocrine modulation of the thymus-dependent immune system: Agonists and mechanisms. In: Jankovic, et al, (Eds.), op cit, pp 39–48.Google Scholar
  184. Halberg, F., 1967, Claude Bernard and the “extreme variability of the internal milieu”. In: “Claude Bernard and Experimental Medicine,” F. Grande & M.B. Visscher (Eds.), Shenkman, Cambridge, Massachusetts, pp 193–210.Google Scholar
  185. Hall, H.H., 1983, Hypnosis and the immune system: A review with implications for cancer and the psychology of healing. Am J Clin Hypnosis, 25: 92–103.CrossRefGoogle Scholar
  186. Hall, N., 1987, Imagery does affect aspects of our physiology. The question is, can it be used to stimulate the immune system? (Interview.) Advances, 4(1): 3.Google Scholar
  187. Hall, N.R., and Goldstein, A.L., 1985, Neurotransmitters and host defense. In Guillemin, et al, (Eds.), op cit, 143–156.Google Scholar
  188. Hall, N.R., and Goldstein, A.L., 1987, Immune system, modulation by the central nervous system. In: Adelman, (Ed.), op cit, pp 523–524.Google Scholar
  189. Hall, N.R., McGillis, J.P., Spangelo, B.L., Healy, D.L., Chrousos, G.P., Schulte, H.M., and Goldstein, A.L., 1985, Thymic hormone effects on the brain and neuroendocrine circuits. In: Guillemin, et al, (Eds.), op cit, 179–193.Google Scholar
  190. Hallam, R.S., 1985, “Anxiety—Psychological Perspectives on Panic and Agoraphobia,” Academic, Orlando, Florida.Google Scholar
  191. Hamburg, D., and Elliott, G., 1981, Biobehavioral sciences: An emerging research agenda. Psychiatr Clin North Am, 407–421.Google Scholar
  192. Hamburg, D.A., Elliott, G.R., and Parron, D.L., 1982, “Health and Behavior: Frontiers of Research in the Biobehavioral Sciences,” Nat Acad Press, Washington, D.C.Google Scholar
  193. Hanley, M.R., 1985, Neuropeptides as mitogens. Nature, 315: 14.PubMedCrossRefGoogle Scholar
  194. Harman, D., 1981, The aging process. Proc Natl Acad Sci USA, 78: 7124–7128.PubMedCrossRefGoogle Scholar
  195. Hastings, A.C., Fadiman, J., and Gordon, J.S., (Eds.), 1980, “Health for the Whole Person: The Complete Guide to Holistic Medicine,” Westview, Boulder, Colorado.Google Scholar
  196. Hazum, E., Chang, K.G., and Cuatrecasas, P., 1979, Specific non-opiate receptors for betaendorphin. Science, 205: 1033–1035.PubMedCrossRefGoogle Scholar
  197. Heijnen, C.J., and Ballieux, R.E., 1986, Influence of opioid peptides on the immune system. Advances, 3(4): 114–121.Google Scholar
  198. Heisel, J.S., Locke, S.E., Kraus, L.J., and Williams, R.M., 1986, Natural killer cell activity and MMPI scores of a cohort of college students. Am J Psychiat, 143: 1382–1386.PubMedGoogle Scholar
  199. Heller, B.W., 1983, Emotion: Toward a biopsychosocial paradigm. In: Temoshok, et al, (Eds.), op cit, pp 189–194.Google Scholar
  200. Hellstrand, K., Hermodsson, S., and Strannegard, 0., 26, Evidence for a beta-adrenoreceptor-mediation regulation of human natural killer cells. J Immunol, 134: 4095–4099.Google Scholar
  201. Helsing, K.J., Szklo, M., and Comstock, G.W., 1981, Factors associated with mortality after widowhood. Am J Public Health, 71: 802–809.PubMedCrossRefGoogle Scholar
  202. Henry, J.P., 1980, Present concept of stress theory. In: “Catecholamines and Stress: Recent Advances,” E. Usdin, R. Kvetnansky & I.J. Kopin (Eds.), Elsevier, New York, pp 557–570.Google Scholar
  203. Henry, J.P., 1982, The relation of social to biological processes in disease. Soc Sci Med, 16: 369–380.PubMedCrossRefGoogle Scholar
  204. Herberman, R., 1982, Possible effects of central nervous system activity on natural killer (NK) cell activity. In: S. Levy, (Ed.), op cit.Google Scholar
  205. Hess, W.R., 1957, “Functional Organization of the Diencephalon,” Grune and Stratton, New York.Google Scholar
  206. Hinkle, L.E., Jr., 1974, The effect of exposure to cultural change, social change, and changes in interpersonal relationships on health. In: Dohrenwend & Dohrenwend, (Eds.), op cit, pp 9–44.Google Scholar
  207. Hiramoto, R.N., Hiramoto, N.S., Solvason, H.B., and Ghanta, V.K., 1987, Regulation of natural immunity (NK activity) by conditioning. In: Jankovic, et al, (Eds.), op cit, pp 545–552.Google Scholar
  208. Hokfelt, T., 1987, Neuronal mapping by transmitter histochemistry with special reference to coexistence of multiple synaptic messengers. In: Adelman, (Ed.), op cit, pp 821–824.Google Scholar
  209. Hokfelt, T., Johansson, O., and Goldstein, M., 1984, Chemical anatomy of the brain. Science, 225: 1326–1334.PubMedCrossRefGoogle Scholar
  210. Holaday, J.W., 1983, Cardiovascular effects of the endogenous opiate system. Ann Rev Pharmacol Toxicol, 23: 541–594.CrossRefGoogle Scholar
  211. Holden, C., 1986a, Manic depression and creativity. Science, 233: 725.PubMedCrossRefGoogle Scholar
  212. Holden, C., 1986b, Researchers grapple with problems of updating classic psychological test. Science, 233: 1249–1251.PubMedCrossRefGoogle Scholar
  213. Holden, C., 1987, Measuring personality. Science, 237: 599.PubMedCrossRefGoogle Scholar
  214. Holmes, T.H., and Rahe, R.H., 1967, The social readjustment rating scale. J Psychosom Res, 11: 213–218.PubMedCrossRefGoogle Scholar
  215. Hoover, R., and Fraumeni, J.F., 1973, Risk of cancer in renal transplant recipients. Lancet, 2: 55–57.PubMedCrossRefGoogle Scholar
  216. Huemer, R.P., 1977, A theory of diagnosis for orthomolecular medicine. J Theoret Biol, 67: 625–635. (1983) [Reprinted with a new footnote.] Advances, 1(3): 52–59.Google Scholar
  217. Hunt, S.P., Pini, A., and Evan, G., 1987, Induction of c-fos-like protein in spinal cord neurons following sensory stimulation. Nature, 328: 632–634.PubMedCrossRefGoogle Scholar
  218. Ingvar, D.H., 1980, Abnormal distribution of cerebral activity in chronic schizophrenia: A neurophysiological interpretation. In: “Perspectives in Schizophrenia Research,” C.F. Baxter & T. Melnechuk (Eds.), Raven, New York, pp 107–130.Google Scholar
  219. Irwin, M., Daniels, M., Bloom, E.T., Smith, T.L., and Weiner, H., 1987, Life events, depressive symptoms, and immune function. Am J Psychiatry, 144: 437–441.PubMedGoogle Scholar
  220. Irwin, M., Vale, W., and Britton, K., 1987, Central corticotrophin-releasing factor suppresses natural killer cytotoxicity. Brain Behavior Immunity, 1: 81–87.CrossRefGoogle Scholar
  221. Ischlondsky, N.D., 1955, The inhibitory process in the cerebro-physiological laboratory and in the clinic. Am J Med Sci, 174: 231–244.Google Scholar
  222. Jacobs, S., and Ostfeld, A., 1977, An epidemiological review of the mortality of bereavement. Psychosom Med, 39: Z344–357.Google Scholar
  223. James, R., and Bradshaw, R.A., 1984, Polypeptide growth factors. Ann Rev Biochem, 53: 259292.Google Scholar
  224. Jankovic, B.D., Markovic, B.M., and Spector, N.H., (Eds.), 1987, Neuroimmune Interactions: Proceedings of the Second International Workshop on Neuroimmunomodulation. Ann N Y Acad Sci, 496: 1–756.Google Scholar
  225. Jansen, M.A., and Muenz, L.R., 1984, A retrospective study of personality variables associated with fibrocystic disease and breast cancer. J Psychosom Res, 28: 35–42.PubMedCrossRefGoogle Scholar
  226. Jasnoski, M.L., 1986, Presentation at the Society for Behavioral Medicine 7th Annual Scientific Sessions, San Francisco, March 5–8.Google Scholar
  227. Jasper, H.H., 1965, Pathological states of brain mechanisms in different states of consciousness. In: “Brain and Conscious Experience,” J.C. Eccles (Ed.), Springer, New York, pp 256–282.CrossRefGoogle Scholar
  228. Jemmot, J.B., Borysenko, J.Z., Borysenko, M., McClelland, D.C., Chapman, R., Meyer, D., and Benson, H., 1983, Academic stress, power motivation and decrease in secretion rate of salivary secretory immunoglobulin A. Lancet, 1: 1400–1402.CrossRefGoogle Scholar
  229. Jenkins, C.D., 1977, Epidemiological studies of of the psychosomatic aspects of coronary heart disease. Adv Psychosom Med, 9: 1–19.Google Scholar
  230. Jerne, N.K., 1984, Idiotypic networks and other preconceived ideas. Immunol Rev, 79: 5–24.PubMedCrossRefGoogle Scholar
  231. Jessel, T.M., 1985, Cellular interactions at the central and peripheral terminals of primary sensory neurons. J Immunology, 135: 746s - 749s.Google Scholar
  232. Jessel, T.M., and Womack, M.D., 1985, Substance P and the novel mammalian tachykinins: A diversity of receptors and cellular actions. Trends In NeuroScience, 8: 43–45.CrossRefGoogle Scholar
  233. Johansson, M., and Sullivan, L., 1975, Influence of treatment and change of climate in women with rheumatoid arthritis. Scand J Rheumatol, suppl 9: 1–193.Google Scholar
  234. Johnson, H.M., and Torres, B.A., 1985, Regulation of lymphokine production by arginine vasopressin and oxytocin: Modulation of lymphocyte function by neurohypophyseal hormones. In: Goetzl, (Ed.), op cit, pp 773s - 775s.Google Scholar
  235. Johnson, H.M., Torres, B.A., Smith, E.M., Dion, L.D., and Blalock, J.E., 1984, Regulation of lymphokine (gamma-interferon) production by corticotropin. J Immunol, 132: 246–250.PubMedGoogle Scholar
  236. Johnson, R.T., Collins, A.R.S., Squires, S., Mullinger, A.M., Elliott, G.C., Downes, C.S., and Rasko, I., 1987, DNA repair under stress. In: Collins, et al, (Eds.), op cit, pp 263–288.Google Scholar
  237. Kahn, R.L., Wethington, E., and Ingersoll-Dayton, 1987, In: “Life-Span Perspective and Social Psychology,” R. Abeles, (Ed.), Erlbaum, Hillsdale, New Jersey, in press.Google Scholar
  238. Kalow, W., Goedde, H.W., and Agarwal, D.P., 1986, “Ethnic Differences in Reactions to Drugs and Xenobiotics,” Liss, New York.Google Scholar
  239. Kasl, S.V., Evans, A.S., and Niederman, J.C., 1979, Psychosocial risk factors in the development of infectious mononucleosis. Psychosom Med, 41: 445–446.PubMedGoogle Scholar
  240. Katayama, M., Kobayashi, S., Kuramoto, N., and Yokoyama, M.M., 1987, Effects of hypothalamic lesions on lymphocyte subsets in mice. In: Jankovic, et al, (Eds.), op cit, pp 366–376.Google Scholar
  241. Kennedy, B., Ziegler, M.G., and Shannahoff-Khalsa, D.S., 1986, Alternating lateralizaton of plasma catecholamines and nasal patency in humans. Life Sci, 38: 1203–1214.PubMedCrossRefGoogle Scholar
  242. Kiecolt-Glaser, J.K., Fisher, L.D., Ogrocki, P., Stout, J.C., Speicher, C.E., and Glaser, R., 1987, Marital quality, marital disruption, and immune function. Psychom Med, 49: 13–34.Google Scholar
  243. Kiecolt-Glaser, J.K., Garner, W., Speicher, C.E., Penn, G., and Glaser, R., 1984, Psychosocial modifiers of immunocompetence in medical students. Psychosom Med, 46: 7–14.PubMedGoogle Scholar
  244. Kiecolt-Glaser, J.K., Glaser, R., Strain, E.C., Stout, J.C., Tarr, K.L., Holliday, J.E., and Speicher, C.E., 1984, Modulation of cellular immunity in medical students. J Behav Med, 9: 5–21.CrossRefGoogle Scholar
  245. Kiecolt-Glaser, J.K., Glaser, R., Williger, D., Stout, J., Messick, G., Sheppard, S., Ricker, D., Romisher, S.C., Briner, W., Bonnell, G., and Donnerberg, R., 1985, Psychosocial enhancement of immunocompetence in a geriatric population. Health Psychol, 4: 25–41.PubMedCrossRefGoogle Scholar
  246. Kiecolt-Glaser, J.K., Ricker, D., George, J., Messick, G., Speicher, C.E., Garner, W., and Glaser, R., 1983, Urinary cortisol levels, cellular immunocompetency, and loneliness in psychiatric inpatients. Psychosom Med, 46: 15–24.Google Scholar
  247. Kiecolt-Glaser, J.K., Stephens, R.E., Lipetz, P.D., Speicher, C.E., and Glaser, R., 1985, Distress and DNA repair in human lymphocytes. J Behav Med, 8: 311–320.PubMedCrossRefGoogle Scholar
  248. Kimura, D., 1987, Sex differences, human brain organization. In: Adelman, (Ed.), op cit, pp 1084–1085.Google Scholar
  249. Klein, R., and Armitage, R., 1979, Rhythms in human performance: (1) 1–1/2 hour oscillations in cognitive style. Science, 204: 1326–1328.PubMedCrossRefGoogle Scholar
  250. Klerman, G.L., and Izen, J.E., 1977, The effects of bereavement and grief on physical health and general well-being. Adv Psychosom Med, 9: 63–104.Google Scholar
  251. Klima, E.S., and Bellugi, U., 1979, “Signs of Language,” Harvard University Press, Cambridge, Massachusetts.Google Scholar
  252. Kluft, R., (Ed.), 1985, “Childhood Antecedents of Multiple Personality,” American Psychiatric Press, Washington, DC.Google Scholar
  253. Knapp, P.H., 1983, Emotions and bodily changes: A reassessment. In: Temoshok, et al, (Eds.), op cit, pp 15–27.Google Scholar
  254. Kobasa, S.C., 1979, Stressful life events, personality and health: An inquiry into hardiness. J Pers Soc Psychol, 37: 1–11.PubMedCrossRefGoogle Scholar
  255. Kobasa, S.C.O., Maddi, S.R., Puccetti, M.C., and Zola, M.A., 1985, Effectiveness of hardiness, exercise, and social support as resources against illness. J Psychosom Res, 29: 525–533.PubMedCrossRefGoogle Scholar
  256. Korneva, E.A., 1987, Electrophysiological analysis of brain reactions to antigen. In: Jankovic, et al, (Eds.), op cit, pp 318–337.Google Scholar
  257. Korneva, E.A., Klimenko, V.M., and Shkhinek, E.K., 1985, “Neural Maintenance of Immune Homeostasis,” [Translated by S and E Corson from the Russian original published in 1978.) University of Chicago Press, Chicago.Google Scholar
  258. Kripke, D., and Sonnenschein, D., 1978, A biological rhythm in waking fantasy. In: “The Stream of Consciousness,” K.S. Pope & J.L. Singer ( Eds. ), Plenum, pp 321–332.Google Scholar
  259. Kronfol, Z., and House, J.D., 1984, Depression, cortisol, and immune function [letter]. Lancet, 1: 1026–1027.PubMedCrossRefGoogle Scholar
  260. Kronfol, Z., House, J.D., Silva, J. Jr., Greden, J., and Carroll, B.J., 1986, Depression, urinary free cortisol excretion, and lymphocyte function. Br J Psychiatry, 148: 70–73.PubMedCrossRefGoogle Scholar
  261. Kronfol, Z., Nair, M.P.N., Soudah, H., Rhodes-Reed, G., Barucha-Reid, R., Schwartz, S.A., and Hawthorne, V.M., 1987, Natural killer cell activity in schizophrenia. Soc Neurosci Abstr, 13: 1583.Google Scholar
  262. Kronfol, Z., Turner, R., Nasrallah, H., and Winokur, G., 1984, Leukocyte regulation in depression and schizophrenia. Psychiat Res, 13: 13–18.CrossRefGoogle Scholar
  263. Krueger, R.B., Levy, E.M., Cathcart, E.S., Fox, B.H., and Black, P.H., 1984, Lymphocyte subsets in patients with major depression: Preliminary findings. Advances, 1(1): 59.Google Scholar
  264. LaBarbra, R.C., 1970, Experimental and environmental factors in cancer. A review of research with animals. Psychosom Med, 32: 259–276.Google Scholar
  265. Lacey, J.I., 1967, Somatic response patterning and stress. In: “Psychological Stress,” M. Appley & R. Trumbull (Eds.), Appleton- Century-Crofts, New York.Google Scholar
  266. Lane, R.D., and Schwartz, G.E., 1987, Induction of lateralized sympathetic input to the heart by the CNS during emotional arousal: A possible neurophysiologic trigger of sudden cardiac death. Psychosom Med, 49: 274–284.PubMedGoogle Scholar
  267. Laudenslager, M., Capitanio, J.P., and Reite, M., 1985, Possible effects of early separation experiences on subsequent immune function in adult Macaque monkeys. Am J Psychiatry, 142: 862–864.PubMedGoogle Scholar
  268. Laudenslager, M.L., Ryan, S.M., Drugan, R.C., Hyson, R.L., and Maler, S.F.,1983, Coping and immunosuppression: Inescapable but not escapable shock suppresses lymphocyte proliferation. Science, 221: 568–570.Google Scholar
  269. Leme, J.C., 1985, The endocrine and nervous systems in inflammation: Pharmacological considerations. In: “Handbook of Inflammation, Vol 5: The Pharmacology of Inflammation,” I.L. Bonta, M.A. Bray & M.J. Parnham (Eds.), Elsevier, New York, pp 195–234.Google Scholar
  270. Lerner, M., and Remen, N., 1985, A variety of integral cancer therapies. Advances, 1(1): 10–15.Google Scholar
  271. LeShan, L.L., and Worthington, R.E., 1956, Personality as factor in pathogenesis of cancer: Review of literature. Br J Med Psychol, 29: 49–56.PubMedCrossRefGoogle Scholar
  272. Levi, L., and Andersson, L., 1975, “Psychosocial Stress—Population, Environment, and Quality of Life,” Spectrum, New York.Google Scholar
  273. Levine, J.D., Clark, R., Devor, M., Helms, C., Moskowitz, M.A., and Basbaum, A.I., 1984, Intraneura1 substance P contributes to the severity of experimental arthritis. Science, 226: 547–549.PubMedCrossRefGoogle Scholar
  274. Levine, S., and Ursin, H., (Eds.), 1980, Coping and Health. NATO Conference Series. Plenum, New York.Google Scholar
  275. Levine, S., Weinberg, J., and Ursin, H., 1978, Definition of the coping process and statement of the problem. In: “Psychobiology of Stress,” H. Ursin (Ed.), Academic, New York.Google Scholar
  276. Levy, S., 1982, “Biological Mediators of Behavior and Disease Neoplasia,” Elsevier, North Holland, New York.Google Scholar
  277. Levy, S.M., 1984, Emotions and the progress of cancer: A review. Advances, 1(1): 10–15.Google Scholar
  278. Levy, S.M., 1985, “Behavior and Cancer,” Jossey-Bass, San Francisco.Google Scholar
  279. Levy, S.M., 1986, Presentation at the Society for Behavioral Medicine 7th Annual Scientific Sessions, San Francisco, March 5–8.Google Scholar
  280. Liebeskind, J.C., Lewis, J.W., Shavit, Y., Terman, G.W., and Melnechuk, T., 1983, Our natural capacities for pain suppression. Advances,1(intro): 8–11.Google Scholar
  281. Lightman, S.L., and Young, W.S. III, 1987, Changes in hypothalamic preproenkeophalin A following stress and opiate withdrawal. Nature, 328: 643–645.PubMedCrossRefGoogle Scholar
  282. Lindquist, S., 1986, The heat-shock response. Ann Rev Biochem, 55: 1151–1191.PubMedCrossRefGoogle Scholar
  283. Lipowsky, Z.J., 1986, Psychosomatic medicine: Past and present (3 parts). Can. J. Psychiatry, 31J: 2–7 (Part I), 8–13 (Part I I ), 14–21 (Part III).Google Scholar
  284. Lipowski, Z.J., 1987, Somatization: Medicine’s unsolved problem. Psychosomtics,28: 294–297.Google Scholar
  285. Lloyd, R., 1984, Stress-induced immunomodulation and cancer: Mechanisms and consequences. Fort Lauderdale, Florida, Jan 28–29,1984. [Conference report] Advances, 1(3): 60–64.Google Scholar
  286. Lloyd, R., 1987, “Explorations in Psychoneuroimmunology,” Grune & Stratton, Orlando, Florida.Google Scholar
  287. Locke, S.E., and Gorman, J.R., 1987, Behavior and immunity. In: “Comprehensive Textbook of Psychiatry,” H. Kaplan & B. Sadock (Eds.), William & Wilkins, Baltimore. In press.Google Scholar
  288. Locke, S.E., and Hornig-Rohan, M., (Eds.), 1983, “Mind and Immunity: Behavioral Immunology,” Institute for the Advancement of Health, New York.Google Scholar
  289. Locke SE, Kraus L (1982) Modulation of natural killer cell activity by life stress and coping ability. In: Levy, ed, op cit, pp 3–28.Google Scholar
  290. Locke, S.E., Ader, R., Besedovsky, H., Hall, N., Solomon, G., and Strom, T., (Eds.), 1985, “Foundations of Psychoneuroimmunology,” Aldine, Hawthorne, New York.Google Scholar
  291. Lopker, A., Abood, L.G., Hoss, W., and Lionetti, F.J., 1980, Stereoselective muscarinic acetylcholine and opiate receptors in human phagocytic leukocytes. Biochem Pharmacol, 29: 1361–1365.PubMedCrossRefGoogle Scholar
  292. Lovett, C.L., Ulrich, J.T., and Simms, B.G., 1978, Effects of chlorpromazine on antibody production in vitro. In: “Neurochemical and Immunologic Components in Schizophrenia,” D. Bergsma & A.L. Goldstein (Eds.), Liss, New York, pp 407–422.Google Scholar
  293. Lundin, T., 1984, Morbidity following sudden and unexpected bereavement. Br J Psychiatry, 144: 84–88.PubMedCrossRefGoogle Scholar
  294. Lynch, J., 1977, “The Broken Heart,” Basic, New York.Google Scholar
  295. McClelland, D.C., Floor, W., Davidson, R.J., and Saron, C., 1980, Stressed power motivation, sympathetic activation, immune function, and illness. J Hum Stress, 6: 11–19.CrossRefGoogle Scholar
  296. McCoy, J.W., 1978, Psychological variables and onset of cancer. Diss Abstr Int, 38: 4471B.Google Scholar
  297. McEwen, B.S., 1980, Steroid hormones and the brain: Cellular mechanisms underlying neural and behavioral plasticity. Psychoneuroendocrinology, 5: 1–11.PubMedCrossRefGoogle Scholar
  298. McManus, I.C., 1977, Predominance of left-sided breast tumors. Lancet, 2: 297–298.PubMedCrossRefGoogle Scholar
  299. Maguire, P., 1979, The will to live in the cancer patient. In: Stoll, ( Ed,.) op cit, pp 169–182.Google Scholar
  300. Mandell, A.J., 1980, Toward a psychobiology of transcendence: God in the brain. In: “The Psychobiology of Consciousness,” J.M. Davidson & R.J. Davidson (Eds.), Plenum, New York, pp 379–464.CrossRefGoogle Scholar
  301. Mandell, J., 1986, Toward a neuropsychopharmacology of habituation: A vertical integration. Review article. Math Modeling, 7: 809–888.CrossRefGoogle Scholar
  302. Mandell, A.J., and Knapp, S., 1979, Asymmetry and mood, emergent properties of serotonin regulation. Arch Gen Psychiatr,y 36: 909–916.CrossRefGoogle Scholar
  303. Mandell, A.J., Russo, P.V., and Knapp, S., 1982, Strange stability in hierarchically coupled neuropsychiobiological systems. In: “Evolution of Order and Chaos in Physics, Chemistry, and Biology,” H. Haken (Ed.), Springer, New York, pp 270–286.CrossRefGoogle Scholar
  304. Mandler, G., 1983, Emotion and stress: A view from cognitive psychology. In: Temoshok, et al, (Eds.), op cit, pp 195–205.Google Scholar
  305. Mann, J.J., Brown, R.P., Halper, J.P., Sweeney, J.A., Kocsis, J.H., Stokes, P.E., and Bilezikian, J.P., 1985, Reduced sensitivity of lymphocyte beta-adrenergic receptors in patients with endogenous depression and psychomotor agitation. N Engl J Med, 313: 715–720.PubMedCrossRefGoogle Scholar
  306. Markert, C.L., 1987, Isozymes and the regulatory structure of the genome. In: “Isozymes: Current Topics in Biological and Medical Research Vol 14: Molecular and Cellular Biology,” M.C. Rattazzi, J.G. Scandalios & G.S. Whitt (Eds.), Liss, New York, pp 1–17.Google Scholar
  307. Martin, J.B., Brownstein, M.J., and Krieger, D.T., 1987, “Brain Peptides Update,” WileyInterscience, New York.Google Scholar
  308. Marx, J.L., 1987a, Oxygen free radicals linked to many diseases. Science, 235: 529–531.PubMedCrossRefGoogle Scholar
  309. Marx, J.L., 1987b, The AIDS virus—well known but a mystery. Science, 236: 390–392.PubMedCrossRefGoogle Scholar
  310. Mason, J.W., 1972, Organization of psychoendocrine mechanisms. A review and a reconsideration of research. In: “Handbook of Psychophysiology,” N.S. Greenfield & R.A. Sternbach (Eds.), Holt, Rinehart, and Winston, New York, pp 3–91.Google Scholar
  311. Mason, J.W., 1974, Specificity in organization of neuroendocrine response profiles. In: “Frontiers in Neurology and Neuroscience Research,” P. Seeman & G.M. Brown (Eds.), University of Toronto, Toronto, pp 68–80.Google Scholar
  312. Mason, J.W., 1975, Emotions as reflected in patterns of endocrine integration. In “Emotions: Their Parameters and Measurement,” L. Levi (Ed.), Raven, New York, pp 143–181.Google Scholar
  313. Massague, J. 1987 ), The TGF-beta family of growth and differentiation factors. Minireview. Cell, 49: 437–438.PubMedCrossRefGoogle Scholar
  314. Matheny, K.B., and Cupp, P., 1983, Control desirability and anticipation as moderating variables between life change and illness. J Human Stress, 9: 14–23.PubMedCrossRefGoogle Scholar
  315. Meares, A., 1978, Regression of osteogenic sarcoma metastases associated with intensive meditation. Med J Aust, 2: 433.PubMedGoogle Scholar
  316. Meares, A., 1980, What can the cancer patient expect from intensive meditation? Aust Family Physician, 9: 322–325.Google Scholar
  317. Meares, A., 1982, A form of intensive meditation associated with the regression of cancer. Am J Clin Hypnosis, 25: 114–121.CrossRefGoogle Scholar
  318. Melnechuk, T., 1983, Neuroimmunomodulation. University of Kentucky, Advances, 1(introductory): 29–31.Google Scholar
  319. Melnechuk, T., 1984a, Society for Neuroscience 13th annual meeting, Boston, Massachusetts, Nov 6–11, 1983. Advances, 1(1): 39–41.Google Scholar
  320. Melnechuk, T., 1984b, A diagnosis and a prescription. [Commentary in verse.] Advances, 1(2): 61–63.Google Scholar
  321. Melnechuk, T., 1984c, How might positive emotions affect physical health? [Conference report.] Advances, 1(3): 4–8.Google Scholar
  322. Melnechuk, T., 1984d, Neural modulation of immunity. University Foundation, Brussels, October 27–28,1983. [Conference report.] Advances, 1(4): 56–59.Google Scholar
  323. Melnechuk, T., 1985a, Society for Neuroscience 14th annual meeting, Anaheim, California, Oct 10–14,1984. Advances, 2(1): 58–63.Google Scholar
  324. Melnechuk, T., 1985, Neuroimmunology: Crossroads between behavior and disease. New York, April 15–16. [Conference report.] Advances, 2(3): 54–58.Google Scholar
  325. Melnechuk, T., 1985c, Progress toward a general theory of health. [Commentary.] Behav Brain Sci, 8: 406–407, 421–426.Google Scholar
  326. Melnechuk, T., 1985d, The biology of music-making. University of Colorado, July 8–12, 1984. [Conference report.] Advances, 2(2): 53–59.Google Scholar
  327. Melnechuk, T., 1985e, Why has psychoneuroimmunology been controversial? Proponents and skeptics at a scientific conference. [Annotated selections from conference discussions.] Advances, 2(4): 22–38.Google Scholar
  328. Melnechuk, T., 1986, Society for Neuroscience 15th annual meeting, Dallas, Texas, Oct 2025, 1985. Advances, 3 (1): 46–51.Google Scholar
  329. Melnechuk, T., and Zatorre, R.J., 1987, Music. In: Adelman, (Ed.), op cit, pp 724–725.Google Scholar
  330. Menaghan, E.G., 1985, Depressive affect and subsequent divorce. J Fam Issues, 6: 295–306.CrossRefGoogle Scholar
  331. Meyer, A., 1957, “Psychobiology: A Science of Man,” Thomas, Springfield, Illinois.Google Scholar
  332. Mezey, E., Reisine, T.D., Brownstein, M.J., Palkovits, M., and Axelrod, J., 1984, Betaadrenergic mechanism of insulin-induced adrenocorticotropin release from the anterior pituitary. Science, 226: 1085–1087.PubMedCrossRefGoogle Scholar
  333. Miles, K., Atweh, S., Otten, G., Amason, B.G.W., and Chelmicka-Schorr, E., 1984, Betaadrenergic receptors on splenic lymphocytes from axotomized mice. J Immunopharm, 6: 171–176.CrossRefGoogle Scholar
  334. Miller, J.G., 1978, “Living Systems,” McGraw-Hill, New York.Google Scholar
  335. Miller, N.E., 1985, Effects of emotional stress on the immune system. Pay J Biol Sci, 20: 47–52.Google Scholar
  336. Milner, B., 1973, Hemispheric specialization: Scope and limits. In: “The Neurosciences: Third Study Program,” F.O. Schmitt & F.G. Worden (Eds.), MIT Press, Cambridge, Massachusetts, pp 75–89.Google Scholar
  337. Minsky, M., 1986,, “The Society of Mind. Simon and Schuster, New York.Google Scholar
  338. Moertel, C.G., 1986, On lymphokines, cytokines, and breakthroughs. DAMA, 256: 3141.Google Scholar
  339. Monjan, A.A., and Collector, M.I., 1977, Stress-induced modulation of the immune response. Science, 196: 307–308.PubMedCrossRefGoogle Scholar
  340. Monroe, S.M., Bromet, E.J.m., Connell, M.M., and Steiner, S.C., 1986, Social support, life events, and depressive symptoms. A one-year prospective study. J Consult Clin Psychol, 54: 424–431.PubMedCrossRefGoogle Scholar
  341. Moore, R.Y., 1987, Hypothalamus. In: Adelman, (Ed.), op cit, pp 317–318.Google Scholar
  342. Mor, V., McHorney, C., and Sherwood, S., 1986, Secondary morbidity among the recently bereaved. Am J Psychiatry, 143: 158–163.PubMedGoogle Scholar
  343. Mueller, J., 1983, Neuroanatomic correlates of emotion. In: Temoshok, et al, (Eds.), op cit, pp 95–121.Google Scholar
  344. Mueller, N., Ackenheil, M., Eckstein, R., Hofschuster, E., and Mempel, W., 19897, Reduced suppressor cell function in psychiatric patients. In: Jankovic, et al, (Eds.), op cit, 686–690.Google Scholar
  345. Nair, R.M.G., Barrett, J.F., Bowers, C.Y., and Schally, A.V., 1970, Structure of porcine thyrotropin-releasing hormone. Biochemistry, 9: 1103–1106.PubMedCrossRefGoogle Scholar
  346. Nakano, Y., Miura, T., Hara, I., Aono, H., Miyano, N., Miyajima, K., Tabuchi, T., and Kosaka, H., 1982, The effect of shift work on cellular immune function. J Hum Ergol, 11 suppl: 131–137.Google Scholar
  347. Nance, D.M., Carr, R., and Nance, P.W., 1985, Effects of unilateral brain damage on the immune system in mice and men. Soc Neurosci Abstr, 11(pt2): 860.Google Scholar
  348. Nasr, S., Altman, E.G., and Meltzer, H.Y., 1981, Concordance of atopic and affective disorders. J Affect Disord 3: 291–296.PubMedCrossRefGoogle Scholar
  349. National Bureau of Standards (1987) Abstracts. 4th International Congress on Oxygen Radicals, La Jolla, California, June 27-July 3.Google Scholar
  350. Nauta, W.J.H., 1973, Connections of the frontal lobe with the limbic system. In: “Surgical Approaches in Psychiatry,” L.V. Laitinen & R.E. Livingston (Eds.), University Park Press, Baltimore, pp 303–314.Google Scholar
  351. Nauta, W.J.H., 1971, The problem of the frontal lobe: A reinterpretation. J Psychiat Res, 8: 167–187.PubMedCrossRefGoogle Scholar
  352. Nemeroff, C.B., Simon, J.S., Haggerty, J.J., Jr., et a1, 1985, Antithyroid antibodies in depressed patients. Am J Psychiatry 142: 840–843.PubMedGoogle Scholar
  353. Neveu, P.J., Taghzouti, K., Dantzer, R., Simon, H., and Le Moal, M., 1986, Modulation of mitogen-induced lymphoproliferation by cerebral neocortex. Life Sci, 38: 1907–1913.PubMedCrossRefGoogle Scholar
  354. Neveu, P.J., Crestani, F., and Le Moal, M., 1987, Conditioned immunosuppression: A new methodological approach. In: Jankovic, et al, (Eds.), op cit, pp 595–601.Google Scholar
  355. Newberry, B.H., Gildow, J., Wogan, J., and Reese, R.L., 1976, Inhibition of Huggins tumors by forced restraint. Psychosom Med, 38: 155–162.PubMedGoogle Scholar
  356. Newton, B.W., 1982–83, The use of hypnosis in the treatment of cancer patients. Am J Clin Hypnosis, 25: 104–113.Google Scholar
  357. Niemi, T., and Jaaskelainin, J., 1978, Cancer morbidity in depressive persons. J Psychosomat Res, 22: 117–120.CrossRefGoogle Scholar
  358. Oke, A., Keller, R., Mefford, I., and Adams, R.N., 1978, Lateralization of norepinephrine in the human thalamus. Science, 200: 1411–1413.PubMedCrossRefGoogle Scholar
  359. O’Regan, B., 1987, Healing, remission, and miracle cures. [Lecture, Dec 5, 1986. ] Special Report. Institute of Noetic Sciences, Sausalito, California.Google Scholar
  360. O’Regan, B., and Hirshberg, C., (Eds.), 1987, “Spontaneous Remission,” Institute of Noetic Sciences, Sausalito, California, in preparation.Google Scholar
  361. Ottaway, C.A., Bernaerts, C., Chan, B., and Greenberg, G.R., 1983, Specific binding of vasoactive intestinal peptide to human circulating mononuclear cells. Can J Physiol Pharmacol, 61: 664–671.PubMedCrossRefGoogle Scholar
  362. Ovadia, H., Lubetzki-Korn, I., and Abramsky, O., 1987, Dopamine receptors on isolated membranes of rat thymocytes. In: Jankovic, et al, (Eds.), op cit, 211–216.Google Scholar
  363. Palmblad, J., Petrini, B., Wasserman, J., and Akerstedt, T., 1979, Lymphocyte and granulocyte reactions during sleep deprivation. Psychosom Med, 41: 273–278.PubMedGoogle Scholar
  364. Panksepp, J., 1981, Hypothalamic integration of behavior: Rewards, punishments, and related psychological processes. In: “Handbook of the Hypothalamus, Vol 3, Pt B, Behavioral Studies of the Hypothalamus,” P. Morgane & J. Panksepp (Eds.), Dekker, New York, pp 289–431.Google Scholar
  365. Panksepp, J., 1985, Mood changes. In: “Handbook of Clinical Neurology, Vol 1(45), Clinical Neuropsychology,” JAM Frederiks (Ed.), Elsevier, New York, pp 271–285.Google Scholar
  366. Panksepp, J., 1986, The anatomy of the emotions. In: “Emotion: Theory, Research, and Experience, Vol 3.,” R. Plutchik (Ed.), Academic, New York, pp 91–124.Google Scholar
  367. Panksepp, J., 1986, The neurochemistry of behavior. Ann. Rev. Psychol., 37: 77–107.CrossRefGoogle Scholar
  368. Parkes, C.M., 1972, “Bereavement: Studies of Grief in Adult Life,” International Universities Press, New York.Google Scholar
  369. Parkes, C.M., 1984, Recent bereavement as a cause of mental illness. Brit J Psychiatry, 110: 198–204.CrossRefGoogle Scholar
  370. Parrillo, J.E., and Fauci, A.S., 1978, Comparison of the effector cells in human spontaneous cellular cytotoxicity and antibody-independent cellular cytotoxicity: Differential sensitivity of effector cells to in vivo and in vitro corticosteroids. Scand J Immunol, 134: 4095–4099.Google Scholar
  371. Pavlov, I.P., 1902, “The Work of the Digestive Glands,” Translated by W.H. Thompson. Lippincott, Philadelphia.Google Scholar
  372. Payan, D.G., Levine, J.D., and Goetzl, J.E., 1984, Modulation of immunity and hypersensitivity by sensory neuropeptides. J Immunol, 132: 1601–1604.PubMedGoogle Scholar
  373. Payan, D.G., McGillis, J.P., Renold, F.K., Mitsuhashi, M., and Goetzl, E.J., 1987, Neuropeptide modulation of leukocyte function. In: Jankovic, et al, (Eds.), op cit, pp 182–191.Google Scholar
  374. Peck, R., 1987, Neuropeptides modulating macrophage function. In: Jankovic, et al, (Eds.), op cit, pp 264–270.Google Scholar
  375. Penn, A., Garte, S.J., Warren, L., Nesta, D., and Mindich, B., 1986, Transforming gene in human atherosclerotic plaque DNA. Proc Natl Acad Sci, 83: 7951–7955.PubMedCrossRefGoogle Scholar
  376. Pert, C.B., Ruff, M.R., Weber, R.J., and Herkenham, M., 1984, Neuropeptides and their receptors: A psychosomatic network. J Immun, 135: 820s - 826s.Google Scholar
  377. Peters, L.J., and Mason, K.A., 1979, Influence of stress on experimental cancer. In: Stoll, (Ed.), op cit, pp 103–123.Google Scholar
  378. Petrov, R.V., Mikhailova, A.A., and Zakharova, L.A., 1987, Myelopeptides: Mediators of interaction between the immune system and the nervous system. In: Jankovic, et al, (Eds.), op cit, pp 271–277.Google Scholar
  379. Pettingale, K.W., 1985, Towards a psychobiological model of cancer: Biological considerations. Soc Sci Med, 20: 779–787.PubMedCrossRefGoogle Scholar
  380. Pfeiffer, A., Brantl, V., Herz, A., and Emrich, H.M., 1986, Psychotomimesis mediated by kappa opiate receptors. Science, 233: 774–776.PubMedCrossRefGoogle Scholar
  381. Pierpaoli, W., Balakrishnan, J., Sche, E., Choay, J., and Maestroni, G.J.M., 1987, Neuroendocrine and bone marrow factors for control of marrow transplantation and tissue regeneration. In: Jankovic, et al, (Eds.), op cit, pp 27–38.Google Scholar
  382. Plaut, S.M., and Friedman, S.B., 1981, Psychosocial factors, stress, and disease processes. In: Ader, (Ed.), op cit, pp 3–30.Google Scholar
  383. Plaut, S.M., and Friedman, S.B., 1985, Biological mechanisms in the relationship of stress to illness. Pediatr Ann, 14: 563–567.PubMedGoogle Scholar
  384. Plutchik, R., 1980, “Emotion: A Psychoevolutionary Synthesis,” Harper & Row, New York.Google Scholar
  385. Plutchik, R., and Ax, A.F., 1967, A critique of determinants of emotional state by Schachter and Singer. Psychophysiology, 4(1): 79–82.Google Scholar
  386. Pochet, R., Delespesse, G., Gausset, P.W., and Collet, H., 1979, Distribution of betaadrenergic receptors on human lynmphocyte subpopulations. Clin Exp Immunol, 38: 578–584.PubMedGoogle Scholar
  387. Prentky, R.A., 1979, Creativity and psychopathology: A neurocognitive perspective. Prog Exp Personality Res, 9: 1–39.Google Scholar
  388. Price, J.L., 1987, The amygdaloid complex. In: G. Adelman (Ed.), op cit, pp 40–42.Google Scholar
  389. Pryor, W.A., 1986, Cancer and free radicals. In: “Antimutagenesis and Anticarcinogenesis Mechanisms,” D.M. Shankel, P.E. Hartman, T. Kada, & A. Hollaender (Eds.), Plenum, New York, pp 45–59.CrossRefGoogle Scholar
  390. Rahe, R.H., 1972, Subjects’ recent life changes and their near-future illness susceptibility. Adv Psychosom Med, 8: 2–19.PubMedGoogle Scholar
  391. Rahe, R.H., 1975, Epidemiological studies of life change and illness. Intern J Psychiatry Med, 6: 133–146.CrossRefGoogle Scholar
  392. Raine, C.S., (Ed.), 1985, Special issue on neuroimmunomodulation. J Neuroimmunol,10: 1–99.Google Scholar
  393. Rees, W.D., and Lutkins, S.G., 1967, Mortality of bereavement. Br Med J, 4: 13–16.PubMedCrossRefGoogle Scholar
  394. Reich, P., DeSilva, R., Lown, B., and Murawski, J., 1981, Acute psychological disturbances preceding life-threatening ventricular arrythmias. DAMA, 246: 233–235.Google Scholar
  395. Reilly, V., Fitzmaurice, M.A., and Spackman, D.H., 1981, Psychoneuroimmunologic factors in neoplasia: Studies in animals. In: R. Ader (Ed.), op cit, pp 31–102.Google Scholar
  396. Renoux, G., Biziere, K., Renoux, M., Bardos, P., and Degenne, D., 1987, Consequences of bilateral brain neocortical ablation on imuthiol-induced immunostimulation in mice. In: Jankovic, et al, (Eds.), op cit, pp 346–353.Google Scholar
  397. Requena, Y., 1986, Acupuncture’s challenge to Western medicine. Advances, 3(2): 46–55.Google Scholar
  398. Roach, A., Adler, J.E., and Black, I.B., 1987, Depolarizing influences regulate preprotachykinin mRNA in sympathetic neurons. Proc Natl Acad Sci USA, 84: 5078–5081.PubMedCrossRefGoogle Scholar
  399. Robinson, R.G., Kubos, K.L., Starr, L.B., Rao, K., and Price, T.R., 1984, Mood disorders in stroke patients: Importance of location of lesion. Brain, 107: 81–93.PubMedCrossRefGoogle Scholar
  400. Rose, R.M., 1980, Endocrine response to stressful psychologica events. Psychiatr Clin North Am, 3: 251–276.Google Scholar
  401. Rossi, G.F., and Rosadini, G., 1967, Experimental analysis of cerebral dominance in man. In: “Brain Mechanisms Underlying Speech and Language,” F.L. Darley (Ed.), Grune and Stratton, New York, pp 167–184.Google Scholar
  402. Roszman, T.L., Cross, R.J., Brooks, W.H., and Markesbery, W.R., 1985, Neuroimmunomodulation: Effects of neural lesions on cellular immunity. In: Guillemin, et al, (Eds.), op cit, pp 95–109.Google Scholar
  403. Ruff, M.R., Hill, J.M., and Pert, C.B., 1987, Neuropeptides (lymphokines, growth factors, and classical hormones) as the biochemicals of emotion: Implications for the biology of cancer. In: NATO Advanced Research Workshop: Neuroimmunomodulation. Interventions in Aging and Cancer. Stromboli, Sicily, Italy, June 7–11. Abstracts of the Reports, p 18.Google Scholar
  404. Sackheim, H.A., Greenberg, M.S., Weiman, A.L., Gur, R.C., Hungerbuhler, J.P., and Geschwind, N., 1982, Hemispheric assymmetry in the expression of positive and negative emotions. Arch Neurol, 39: 210–218.CrossRefGoogle Scholar
  405. Salk, J., 1972, The mind of man. In: J. Salk, “Man Unfolding,” Harper & Row, New York, pp 107–112.Google Scholar
  406. Sandblom, P., 1985, “Creativity and Disease: How Illness Affects Literature, Art, and Music,” Stickley, Philadelphia.Google Scholar
  407. Saper, C.B., Loewy, A.D., Swanson, L.W., and Cowan, W.M., 1976, Direct hypothalamoautonomic connections. Brain Research, 117: 305–312.PubMedCrossRefGoogle Scholar
  408. Sapolsky, R.M., 1987, Glucocorticoids and hippocampal damage. Trends in NeuroScience, 10: 346–349.CrossRefGoogle Scholar
  409. Saver, J., and Denlinger, S., 1985, Which doctor is not a witch doctor? Advances, 2(1): 20–30.Google Scholar
  410. Schachter, S., and Singer, J.E., 1962, Cognitive, social, and physiological determinants of emotional state. Pyschol Rev, 69: 379–399.CrossRefGoogle Scholar
  411. Schindler, B.A., 1985, Stress, affective disorders, and immune function. Med Clin North Am, 69: 585–597.PubMedGoogle Scholar
  412. Schleifer, S.J., Keller, S.E., Camerino, M., Thornton, J.C., and Stein, M., 1983, Suppression of lymphocyte stimulation following bereavement. DAMA, 250: 374–377.Google Scholar
  413. Schleifer, S.J., Keller, S.E., Meyerson, A.T., Raskin, M.J., Davis, K.L., and Stein, M., 1984, Lymphocyte function in major depressive disorder. Arch Gen Psychiatr, 41: 484–486.PubMedCrossRefGoogle Scholar
  414. Schleifer, S.J., Keller, S.E., Skis, S.G., Davis, K.L., and Stein, M., 1985, Depression and immunity: Lymphocyte function in ambulatory depressed patients, hospitalized schizophrenic patients, and patients hospitalized for herniography. Arch Gen Psychiatry, 42: 129–133.PubMedCrossRefGoogle Scholar
  415. Selye, H., 1936, A syndrome produced by diverse nocuous agents. Nature, 138: 32.CrossRefGoogle Scholar
  416. Selye, H., 1946, The general adaptation syndrome and the diseases of adaptation. J Clin Endocrinol, 6: 117–196.CrossRefGoogle Scholar
  417. Selye, H., 1956, “The Stress of Life,” McGraw-Hill, New York.Google Scholar
  418. Selye, H., 1976, “Stress in Health and Disease,” Butterworth, Boston.Google Scholar
  419. Serafetinides, E.A., 1965, The significance of the temporal lobes and of hemispheric dominance in the production of LSD-25 symptomatology in man. Neuropsychologia, 3: 69–79.CrossRefGoogle Scholar
  420. Setlow, R.B., 1983, Variations in DNA repair among humans. In: “Human Carcinogenesis,” C.H. Curtis & N.A. Herman ( Eds.),Academic, New York, pp 231–254.Google Scholar
  421. Shannahoff-Khalsa, D., 1987, A contemporary view of life force biology: The merging of Kundalini Yoga and the neurosciences. Presented at the First International Conference for Energy Medicine, Feb 27-Mar 1, Madras, India. In: T.M. Srinivasan (Ed.), Proceedings of, etc. Fetzer Energy Medicine Research Institute, Phoenix, Arizona, in press.Google Scholar
  422. Shannahoff-Khalsa, D.S., and Bhajan, Y., 1986, Sound current therapy and self-healing: The ancient science of Nad and Mantra Yoga. Presented at the Third International Symposium for Music in Medicine, Ludenscheid, Federal Republic of Germany, Oct 11–12. In: R. Spintge & R. Droh R, (Eds.), Proceedings of, etc. Springer, Heidelberg, in press.Google Scholar
  423. Shapiro, E.G., and Rosenfeld, A.A., 1987, “The Somatizing Child: Diagnosis and Treatment of Conversion and Somatization Disorders,” Springer, New York.CrossRefGoogle Scholar
  424. Shapiro, H.M., and Strom, T.B., 1980, Electrophysiology of T lymphocyte cholinergic receptors. Proc Natl Acad Sci LISA, 77: 4317–4321.CrossRefGoogle Scholar
  425. Shekelle, R.B., Raynor, W.J. Jr., Ostfeld, A.M., Garron, D.C., Bieliauskas, L.A., Liu, S.C., Maliza, C., and Paul, 0., 1981, Psychological depression and 17- year risk of death from cancer. Psychosom Med, 43: 117–125.PubMedGoogle Scholar
  426. Sherman, N.A., Smith, R.S., and Middleton, E., Jr., 1973, Effect of adrenergic compounds, aminophylline and hydrocortisone, on in vitro immunoglobulin synthesis by normal human peripheral lymphocytes. J Allergy Clin Immunol, 52: 13–22.PubMedCrossRefGoogle Scholar
  427. Shuchter, S., 1986, ‘Dimensions of Grief: Adjusting to the Death of a Spouse,“ Jossey-Bass, San Francisco.Google Scholar
  428. Siegel, B.S., 1986, “Love, Medicine, and Miracles,” Harper & Row, New York. Silberman, E.K., and Weingartner, H., 1986, Hemispheric lateralization of functions related to emotion. Brain Cogn, 5: 322–353.CrossRefGoogle Scholar
  429. Simic, M.G., Grossman, L., and Upton, A.C., 1986, “Mechanisms of DNA Damage and Repair,” Plenum, New York.Google Scholar
  430. Simonton, O.C., Matthews-Simonton, S., and Creighton, J., 1978, “Getting Well Again,” Tarcher, Los Angeles.Google Scholar
  431. Simonton, O.C., Matthews-Simonton, S., and Sparks, T.F., 1980, Psychological intervention in the treatment of cancer. Psychosomatics, 21: 226–233.PubMedGoogle Scholar
  432. Sklar, L.S., and Anisman, H., 1979, Stress and coping factors influence tumor growth. Science, 205: 513–515.PubMedCrossRefGoogle Scholar
  433. Smuts, J.C., 1926, “Holism and Evolution,” Macmillan, New York.Google Scholar
  434. Smith, O.A., 1987, Emotion, neural substrates. In: Adelman, (Ed.), op cit, pp 385–386. Smith, O.A., and DeVito, J.L., 1984, Central neural integration for the control of autonomic responses associated with emotion. Ann Rev Neurosci, 7: 43–65.Google Scholar
  435. Snow, E.C., 1985, Insulin and growth hormone function as minor growth factors which potentiate lymphocyte activation. In: Goetzl, (Ed.), op cit, pp 776s - 778s.Google Scholar
  436. Solomon, G.F., 1981a, Emotional and personality factors in the onset and course of autoimmune disease, particularly rheumatoid arthritis. In: Ader, (Ed.), op cit, pp 159–182.Google Scholar
  437. Solomon, G.F., 1981b, Immunologic abnormalities in mental illness In: Ader, ( Ed.), op cit, pp 259–278.Google Scholar
  438. Solomon, G.F., 1985, The emerging field of psychoneuroimmunology— with a special note on AIDS. Advances, 2(1): 6–19.Google Scholar
  439. Solomon, G.F., 1987, Psychoneuroimmunology. In: Adelman, ( Ed.), op cit, pp 1001–1004.Google Scholar
  440. Solomon, G.F., and Amkraut, A.A., 1983, Emotions, immunity, and disease. In: Temoshok, et al, (Eds.), op cit, pp 167–186.Google Scholar
  441. Solomon, G.F., Fiatarone, M.A., Benton, D., Morley, J.E., Bloom, E., and Makinodan, T., 1987, Psychoimmunologic and endorphin function in the aged. In: Ann NYAcad Sci in press.Google Scholar
  442. Somers, A.R., 1979, Marital status, health, and use of health services. J Marriage Fam, 41: 267–285.CrossRefGoogle Scholar
  443. Spector, N.H., (Ed.), 1985, Neuroimmunomodulation: Proceedings of the First International Workshop on Neuroimmunomodulation. International Working Group on Neuroimmunomodulation (WGN), c/o Fundamental Neurosciences Program, NINCDS, NIH, Rm 916, Federal Bldg, Bethesda, Maryland.Google Scholar
  444. Spector, N.H., 1987, Neuroimmunomodulation. In: Adelman, (Ed.), op cit, pp 798–799. Spector, N.H., and Korneva, E.A., 1981, Neurophysiology, immunophysiology, and neuroimmunomodulation. In: Ader, (Ed.), op cit, pp 449–473.Google Scholar
  445. Sporn, M.B., and Roberts, A.B., 1986, Peptide growth factors and inflammation, tissue repair, and cancer. J Clin Investigation, 78: 329–332.CrossRefGoogle Scholar
  446. Squire, L.R., 1987, “Memory and Brain,” Oxford University Press, New York.Google Scholar
  447. Stanisz, A.M., Scicchitano, R., Payan, D.G., and Bienenstock, J., 1987 ), In vitro studies of immunoregulation by substance P and somatostatin. In: Jankovic, et al, (Eds.), op cit, 217–225.Google Scholar
  448. Stanwyck, D.J., and Anson, C.A., 1986, Is personality related to illness? Cluster profiles of aggregated data. Advances, 3(2): 4–15.Google Scholar
  449. Stein, M., 1985, Bereavement, depression, stress, and immunity. In: Guillemin, et al, (Eds.), op cit, pp 29–44.Google Scholar
  450. Stein, M., 1986, A reconsideration of specificity in psychosomatic medicine: From olfaction to the lymphocyte. Psychosom Med, 48: 3–22.PubMedGoogle Scholar
  451. Stein, M., Schleifer, S.J., and Keller, S.E., 1981, Hypothalamic influences on immune responses. In: R. Ader, (Ed.), op cit, pp 429–473.Google Scholar
  452. Stites, D.P., Stobo, J.D., and Wells, J.V., 1987, `Basic & Clinical Immunology 6th ed.,“ Appleton & Lange, Norwalk, Connecticut.Google Scholar
  453. Stoddard, J.B., and Henry, J.P., 1985, Affectional bonding and the impact of bereavement. Advances, 2(2): 19–28.Google Scholar
  454. Stoll, B.A., 1979, Is hope a factor in survival? In: B.A. Stoll (Ed,.) op cit, pp 183–197.Google Scholar
  455. Stoll, B.A., (Ed.), 1979, “Mind and Cancer Prognosis,” Wiley, Chichester, England.Google Scholar
  456. Stone, A.A., Cox, D.S., Valdimarsdottir, and Neale, J.M., 1987, Secretory IgA as a measure of immunocompetence. J Hum Stress, (Fall): 136–140.Google Scholar
  457. Stoney, C.M., Davis, M.C., and Matthews, K.A., 1987, Sex differences in responses to stress and in coronary heart disease: A causal link?. Psychophysiology, 24: 127–131.PubMedCrossRefGoogle Scholar
  458. Stossel, T.P., 1987, The molecular biology of phagocytes and the molecular basis of nonneoplastic phagocyte disorders. In: “The Molecular Basis of Blood Diseases,” G. Stamatoyannopoulos A.W. Nienhuis, P. Leder & P.W. Majerus (Eds.), Saunders, Philadelphia, pp 499–533.Google Scholar
  459. Stricker, G., 1967, A pre-experimental inquiry concerning cognitive determinants of emotional state. J Gen Psychol, 76: 73–79.PubMedCrossRefGoogle Scholar
  460. Strobel, H.W., Fang, W-F., Takazawa, R.S., Stralka, D.J., Newaz, S.N., Kurzban, G.P., Neslon, D.R., and Beyer, R.S., 1986, Cytochromes p-450 and the activation and inactivatiion of mutagens and carcinogens. In: “Antimutagenesis and Anticarcinogenesis Mechanisms,” D.M. Shankel, P.E. Hartman, T.A. Kada & A. Hollaender (Eds.), Plenum, New York, pp 61–71.CrossRefGoogle Scholar
  461. Stroebe, M.S., and Stroebe, W., 1983, Who suffers more? Sex differences in health risks of the widowed. Psychol Bull, 93: 279–301.PubMedCrossRefGoogle Scholar
  462. Swanson, L.W., 1987, The limbic system. In: Adelman, ( Ed.), op cit, 589–591.Google Scholar
  463. Swanson, L.W., Sawchenko, P.E., and Lind, R.W., 1986, Regulation of multiple peptides in CRF parvocellular neurosecretory neurons: Implications for the stress response. In: T. Hokfelt, K. Fuxe & B. Pernow (Eds.), “Prog Brain Res, Vol 68,” Elsevier, New York, pp 169–90.CrossRefGoogle Scholar
  464. Tallai, N., and Hadden, J., 1985, Hormones, immunomodulating drugs and auto-immunity. In: “Handbook of Inflammation, Vol 5: The Pharmacology of Inflammation,” I.L. Bonta, M.A. Bray & M.J. Parnham (Eds.), Elsevier, New York, pp 355–369.Google Scholar
  465. Tallman, J.F., and Gallagher, D.W., 1985, The GABA-ergic system: A locus of benzodiazepine action. Ann Rev Neurosci, 8: 21–44.PubMedCrossRefGoogle Scholar
  466. Temoshok, L., 1986, Presentation at the Society for Behavioral Medicine 7th Annual Scientific Sessions, San Francisco, March 5–8.Google Scholar
  467. Temoshok, L., and Fox, B.H., (Eds.), 1986, International issue. Advances, 3(4): 1–179. Temoshok, L., Van Dyke, C., and Zegans, L.S., (Eds.), 1983, “Emotions in Health and Illness,” Grune and Stratton, New York.Google Scholar
  468. Tennenbaum, J.I., Ruppert, R.D., and St. Pierre, R.L., et a1, 1969, The effect of chronic alcohol administration on the immune responsiveness of rats. J Allergy, 44: 272–281.Google Scholar
  469. Thatcher, R.W., Walker, R.A., and Giudice, S., 1987, Human cerebral hemispheres develop at different rates and ages. Science, 236: 1110–1113.PubMedCrossRefGoogle Scholar
  470. Theorell, T., 1986, Research on stress and health in Sweden from 1950 to 1985. Advances, 3(4): 92–104.Google Scholar
  471. Thomas, L., 1987, What doctors don’t know. [Review of Becoming a Doctor: A Journey of Initiation in Medical School, by Melvin Konner.] N Y Rev Bks, 34(Sep 24): 6–11.Google Scholar
  472. Tice, R., and Setlow, R., 1985, DNA repair and replication in aging organisms. In: “Handbook of the Biology of Aging,” C.E. Finch & E.L. Schneider (Eds.), Raven, New York, pp 173–224.Google Scholar
  473. Tucker, D., 1981, Lateral brain function, emotion and conceptualization. Psycho! Bull, 89: 19–46.CrossRefGoogle Scholar
  474. Udelman, H.D., and Udelman, D.L., 1985, Hope as a factor in remission of illness. Stress Med, 1: 291–294.CrossRefGoogle Scholar
  475. Ulrich, R.S., 1984, View through a window may influence recovery from surgery. Science, 224: 420–421.PubMedCrossRefGoogle Scholar
  476. Vale, W., Spiess, J., Rivier, C., and Rivier, J., 1981, Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin. Science, 213: 1394–1397.PubMedCrossRefGoogle Scholar
  477. Van Dyke, C., and Kaufman, I., 1983, Psychobiology of bereavement. In: Temoshok, et al, (Ed.), op cit, pp 37–49.Google Scholar
  478. Villemain, F., Chatenoud, L., Guillibert, E., Pelicier, Y., and Bach, J.F., 1987, Decreased production of interleukin-2 in schizophrenia. In: B.D. Jankovic, et al, (Eds.), op cit, pp 669–685.Google Scholar
  479. Vingerhoets, A.J., 1985, The role of the parasympathetic division of the autonomic nervous system in stress and the emotions. Int J Psychosom, 32: 28–34.PubMedGoogle Scholar
  480. Vogel, W.H., 1985, Coping, stress, stressors, and health consequences. Neuropsychobiology, 13: 129–135.PubMedCrossRefGoogle Scholar
  481. Wallerstein, R.S., 1983, Historical perspective. In: Temoshok, et al, (Eds.), op cit, pp 3–5.Google Scholar
  482. Warner, H.R., Butler, R.N., Sprott, R.L., and Schneider, E.L., (Eds.), 1987, “Modern Biological Theories of Aging,” Raven, New York.Google Scholar
  483. Weiner, H., 1977, ‘Psychobiology and Human Disease,“ American Elsevier, New York.Google Scholar
  484. Weiner, H., 1985a, Psychosomatic medicine and the mind-body problem in psychiatry. In: “Handbook of the History of Psychiatry,” Wallace, E IV, (Ed.), Yale University Press, New Haven, Connecticut, in press.Google Scholar
  485. Weiner, H., 1985b, The concept of stress in the light of studies of disasters, unemployment, and loss: A critical review. In: “Stress in Health and Disease,” M.R. Zales (Ed.), Brunner-Mazel, New York, pp 24–94.Google Scholar
  486. Weiss, S.M., 1983, Health and illness: The behavioral medicine perspective. In: Temoshok, et al, (Eds.), op cit, pp 7–14.Google Scholar
  487. Werner, H., Paegelow, I., Meyer-Rienecker, H., and Bienert, M., 1987, Interaction between lymphocytes and neurotransmitters. In: Jankovic, et al, (Eds.), op cit, pp 312–315.Google Scholar
  488. Werntz, D., Bickford, R.G., Bloom, F.E., and Shannahoff-Khalsa, D., 1983, Alternating cerebral hemispheric activity and the lateralization of autonomic nervous function. Human Neurobiology, 2: 39–43.PubMedGoogle Scholar
  489. Werntz D, Bickford RG, Shannahoff-Khalsa D (1987) Selective hemispheric stimulation by unilateral forced nostril breathing. Human Neurobiology in press.Google Scholar
  490. White, L., Tursky, B., and Schwartz, G.E., 1984, Possible determinants of placebo response: A list. Advances, 1(3): 25.Google Scholar
  491. Whitlock, F.A., and Siskind, M., 1979, Depression and cancer: A follow-up study. Psychol Med, 9: 747–752.PubMedCrossRefGoogle Scholar
  492. Wiedermann, C.J., Sertl, K., and Pert, C.B., 1987, Neuropeptides and the immune system: Substance P receptors in bronchus-associated lymphoid tissue of rat. In: Jankovic et al, (Eds.), op cit, pp 205–210.Google Scholar
  493. Williams, C.A., 1987, The second international workshop on neuroimmunomodulation: A report. J Immunol, 13: 343–348.Google Scholar
  494. Williams, L.T., Snyderman, R., and Lefkowitz, R.J., 1976, Identification of beta-adrenergic receptors in human lymphocytes by (-)[3H] alprenolol binding. J Clin Invest, 57: 149–155.PubMedCrossRefGoogle Scholar
  495. Witelson, S.F., 1987, Brain asymmetry, functional aspects. In: G. Adelman, (Ed.), op cit, pp 151–156.Google Scholar
  496. Wolf, S.G., and Goodell, H., 1976, “Behavioral Science in Clinical Medicine,” Thomas, Springfield, Illinois.Google Scholar
  497. Wolff, H.G., 1953, “Stress and Disease,” Thomas, Springfield, Illinois.Google Scholar
  498. Woo, S.L.C., and O’Malley, B.W., 1975, Hormone inducible messenger RNA. Life Sci, 17: 1039–1048.PubMedCrossRefGoogle Scholar
  499. Wood, C., 1987, Buffer of hardiness: An interview with Suzanne C. Ouellette Kobasa. Advances, 4(1): 37–25.Google Scholar
  500. Wybran, J., 1985, Enkephalins, endorphins, Substance P, and the immune system. In: Guillemin, et al, (Eds.), op cit, pp 157–161.Google Scholar
  501. Young, M., Benjamin, B., and Wallis, C., 1963, Mortality of widowers. Lancet, 2: 454–456.PubMedCrossRefGoogle Scholar
  502. Zaidel, E., 1985, Right hemisphere language. In: Benson & Zaidel, (Eds.), op cit, pp 205–236. Zasloff, M., Magainins: A class of antimicrobial peptides from Xenopus skin: IsolationGoogle Scholar
  503. characterization of two active forms, and partial cDNA sequence of a precursor. Proc Natl Acad Sci USA, 84: 5449–5453.Google Scholar
  504. Zavala, F., and Lenfant, M., 1987, Benzodiazepines and PK 11195 exert immunomodulating activities by binding to a specific receptor on macrophages. In: Jankovic, et al, (Eds.), op cit, pp 240–249.Google Scholar
  505. Zegans, L.S., 1983, Emotions in health and illness: An attempt at integration. In: Temoshok, et al, (Eds.), op cit, pp 235–256.Google Scholar
  506. Zoon, K.C., Karasaki, Y., zur Nedden, D.L., Hu, R., and Arnheiter, H., 1986, Modulation of epidermal growth factor receptors by human alpha interferon. Proc Natl Acad Sci USA, 83: 8226–8230.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1988

Authors and Affiliations

  • Theodore Melnechuk
    • 1
    • 2
  1. 1.Neuroimmune Physiology LaboratoryHelicon FoundationSan DiegoUSA
  2. 2.Department of Neurosciences, A-001 School of MedicineUniversity of California San DiegoLa JollaUSA

Personalised recommendations